| Year |
Citation |
Score |
| 2024 |
Hofmann A, Häsler LM, Lambert M, Kaeser SA, Gräber-Sultan S, Obermüller U, Kuder-Buletta E, la Fougere C, Laske C, Vöglein J, Levin J, Fox NC, Ryan NS, Zetterberg H, Llibre-Guerra JJ, ... ... Gordon BA, et al. Comparative neurofilament light chain trajectories in CSF and plasma in autosomal dominant Alzheimer's disease. Nature Communications. 15: 9982. PMID 39557867 DOI: 10.1038/s41467-024-52937-8 |
0.364 |
|
| 2024 |
Vermunt L, Sutphen CL, Dicks E, de Leeuw DM, Allegri RF, Berman SB, Cash DM, Chhatwal JP, Cruchaga C, Day GS, Ewers M, Farlow MR, Fox NC, Ghetti B, Graff-Radford NR, ... ... Gordon BA, et al. Axonal damage and inflammation response are biological correlates of decline in small-world values: a cohort study in autosomal dominant Alzheimer's disease. Brain Communications. 6: fcae357. PMID 39440304 DOI: 10.1093/braincomms/fcae357 |
0.443 |
|
| 2024 |
Shen Y, Timsina J, Heo G, Beric A, Ali M, Wang C, Yang C, Wang Y, Western D, Liu M, Gorijala P, Budde J, Do A, Liu H, Gordon B, et al. CSF proteomics identifies early changes in autosomal dominant Alzheimer's disease. Cell. PMID 39332414 DOI: 10.1016/j.cell.2024.08.049 |
0.576 |
|
| 2024 |
Sewell KR, Doecke JD, Xiong C, Benzinger T, Masters CL, Laske C, Jucker M, Lopera F, Gordon BA, Llibre-Guerra J, Levin J, Huey ED, Hassenstab J, Schofield PR, Day GS, et al. Longitudinal associations between exercise and biomarkers in autosomal dominant Alzheimer's disease. Alzheimer's & Dementia : the Journal of the Alzheimer's Association. PMID 39324510 DOI: 10.1002/alz.14270 |
0.694 |
|
| 2024 |
Daniels AJ, McDade E, Llibre-Guerra JJ, Xiong C, Perrin RJ, Ibanez L, Supnet-Bell C, Cruchaga C, Goate A, Renton AE, Benzinger TLS, Gordon BA, Hassenstab J, Karch C, Popp B, et al. 15 Years of Longitudinal Genetic, Clinical, Cognitive, Imaging, and Biochemical Measures in DIAN. Medrxiv : the Preprint Server For Health Sciences. PMID 39148846 DOI: 10.1101/2024.08.08.24311689 |
0.711 |
|
| 2024 |
McDade E, Liu H, Bui Q, Hassenstab J, Gordon B, Benzinger T, Shen Y, Timsina J, Wang L, Sung YJ, Karch C, Renton A, Daniels A, Morris J, Xiong C, et al. Ubiquitin-Proteasome System in the Different Stages of Dominantly Inherited Alzheimer's Disease. Research Square. PMID 39108475 DOI: 10.21203/rs.3.rs-4202125/v1 |
0.717 |
|
| 2024 |
Schultz SA, Liu L, Schultz AP, Fitzpatrick CD, Levin R, Bellier JP, Shirzadi Z, Joseph-Mathurin N, Chen CD, Benzinger TLS, Day GS, Farlow MR, Gordon BA, Hassenstab JJ, Jack CR, et al. γ-Secretase activity, clinical features, and biomarkers of autosomal dominant Alzheimer's disease: cross-sectional and longitudinal analysis of the Dominantly Inherited Alzheimer Network observational study (DIAN-OBS). The Lancet. Neurology. PMID 39074479 DOI: 10.1016/S1474-4422(24)00236-9 |
0.677 |
|
| 2024 |
Wisch JK, Gordon BA, Barthélemy NR, Horie K, Henson RL, He Y, Flores S, Benzinger TLS, Morris JC, Bateman RJ, Ances BM, Schindler SE. Predicting continuous amyloid PET values with CSF tau phosphorylation occupancies. Alzheimer's & Dementia : the Journal of the Alzheimer's Association. PMID 39041391 DOI: 10.1002/alz.14132 |
0.687 |
|
| 2024 |
Kumar S, Earnest T, Yang B, Kothapalli D, Aschenbrenner AJ, Hassenstab J, Xiong C, Ances B, Morris J, Benzinger TLS, Gordon BA, Payne P, Sotiras A. Analyzing heterogeneity in Alzheimer Disease using multimodal normative modeling on imaging-based ATN biomarkers. Arxiv. PMID 39010871 |
0.626 |
|
| 2024 |
Brier MR, Schindler SE, Salter A, Perantie D, Shelley N, Judge B, Keefe S, Kirmess KM, Verghese PB, Yarasheski KE, Venkatesh V, Raji CA, Gordon BA, Bateman RJ, Morris JC, et al. Unexpected Low Rate of Amyloid-β Pathology in Multiple Sclerosis Patients. Annals of Neurology. PMID 38963256 DOI: 10.1002/ana.27027 |
0.64 |
|
| 2024 |
Yang B, Earnest T, Kumar S, Kothapalli D, Benzinger T, Gordon B, Sotiras A. Evaluation of ComBat harmonization for reducing across-tracer biases in regional amyloid PET analyses. Medrxiv : the Preprint Server For Health Sciences. PMID 38947044 DOI: 10.1101/2024.06.14.24308952 |
0.454 |
|
| 2024 |
Chaloemtoem A, Thornton V, Chang Y, Anokhin AP, Belloy ME, Bijsterbosch J, Gordon BA, Hartz SM, Bierut LJ. Hippocampal volumes in UK Biobank are associated with APOE only in older adults. Medrxiv : the Preprint Server For Health Sciences. PMID 38883747 DOI: 10.1101/2024.06.05.24307704 |
0.337 |
|
| 2024 |
Fan S, Ponisio MR, Xiao P, Ha SM, Chakrabarty S, Lee JJ, Flores S, LaMontagne P, Gordon B, Raji CA, Marcus DS, Nazeri A, Ances BM, Bateman RJ, Morris JC, et al. AmyloidPETNet: Classification of Amyloid Positivity in Brain PET Imaging Using End-to-End Deep Learning. Radiology. 311: e231442. PMID 38860897 DOI: 10.1148/radiol.231442 |
0.647 |
|
| 2024 |
Iaccarino L, Llibre-Guerra JJ, McDade E, Edwards L, Gordon B, Benzinger T, Hassenstab J, Kramer JH, Li Y, Miller BL, Miller Z, Morris JC, Mundada N, Perrin RJ, Rosen HJ, et al. Molecular neuroimaging in dominantly inherited versus sporadic early-onset Alzheimer's disease. Brain Communications. 6: fcae159. PMID 38784820 DOI: 10.1093/braincomms/fcae159 |
0.708 |
|
| 2024 |
Earnest T, Bani A, Ha SM, Hobbs DA, Kothapalli D, Yang B, Lee JJ, Benzinger TLS, Gordon BA, Sotiras A. Data-driven decomposition and staging of flortaucipir uptake in Alzheimer's disease. Alzheimer's & Dementia : the Journal of the Alzheimer's Association. PMID 38683905 DOI: 10.1002/alz.13769 |
0.571 |
|
| 2024 |
Wagemann O, Liu H, Wang G, Shi X, Bittner T, Scelsi MA, Farlow MR, Clifford DB, Supnet-Bell C, Santacruz AM, Aschenbrenner AJ, Hassenstab JJ, Benzinger TLS, Gordon BA, Coalier KA, et al. Downstream Biomarker Effects of Gantenerumab or Solanezumab in Dominantly Inherited Alzheimer Disease: The DIAN-TU-001 Randomized Clinical Trial. Jama Neurology. PMID 38683602 DOI: 10.1001/jamaneurol.2024.0991 |
0.683 |
|
| 2024 |
Levin J, Baiardi S, Quadalti C, Rossi M, Mammana A, Vöglein J, Bernhardt A, Perrin RJ, Jucker M, Preische O, Hofmann A, Höglinger GU, Cairns NJ, Franklin EE, Chrem P, ... ... Gordon BA, et al. α-Synuclein seed amplification assay detects Lewy body co-pathology in autosomal dominant Alzheimer's disease late in the disease course and dependent on Lewy pathology burden. Alzheimer's & Dementia : the Journal of the Alzheimer's Association. PMID 38666355 DOI: 10.1002/alz.13818 |
0.664 |
|
| 2024 |
Wisch JK, McKay NS, Boerwinkle AH, Kennedy J, Flores S, Handen BL, Christian BT, Head E, Mapstone M, Rafii MS, O'Bryant SE, Price JC, Laymon CM, Krinsky-McHale SJ, Lai F, ... ... Gordon BA, et al. Comparison of tau spread in people with Down syndrome versus autosomal-dominant Alzheimer's disease: a cross-sectional study. The Lancet. Neurology. 23: 500-510. PMID 38631766 DOI: 10.1016/S1474-4422(24)00084-X |
0.722 |
|
| 2024 |
McKay NS, Millar PR, Nicosia J, Aschenbrenner AJ, Gordon BA, Benzinger TLS, Cruchaga CC, Schindler SE, Morris JC, Hassenstab J. Pick a PACC: Comparing domain-specific and general cognitive composites in Alzheimer disease research. Neuropsychology. PMID 38602816 DOI: 10.1037/neu0000949 |
0.778 |
|
| 2024 |
Doering S, McCullough A, Gordon BA, Chen CD, McKay N, Hobbs D, Keefe S, Flores S, Scott J, Smith H, Jarman S, Jackson K, Hornbeck RC, Ances BM, Xiong C, et al. Deconstructing pathological tau by biological process in early stages of Alzheimer disease: a method for quantifying tau spatial spread in neuroimaging. Ebiomedicine. 103: 105080. PMID 38552342 DOI: 10.1016/j.ebiom.2024.105080 |
0.71 |
|
| 2024 |
Salvadó G, Horie K, Barthélemy NR, Vogel JW, Pichet Binette A, Chen CD, Aschenbrenner AJ, Gordon BA, Benzinger TLS, Holtzman DM, Morris JC, Palmqvist S, Stomrud E, Janelidze S, Ossenkoppele R, et al. Disease staging of Alzheimer's disease using a CSF-based biomarker model. Nature Aging. PMID 38514824 DOI: 10.1038/s43587-024-00599-y |
0.71 |
|
| 2024 |
Meeker KL, Luckett PH, Barthélemy NR, Hobbs DA, Chen C, Bollinger J, Ovod V, Flores S, Keefe S, Henson RL, Herries EM, McDade E, Hassenstab JJ, Xiong C, Cruchaga C, ... ... Gordon BA, et al. Comparison of cerebrospinal fluid, plasma and neuroimaging biomarker utility in Alzheimer's disease. Brain Communications. 6: fcae081. PMID 38505230 DOI: 10.1093/braincomms/fcae081 |
0.718 |
|
| 2024 |
Li Y, Yen D, Hendrix RD, Gordon BA, Dlamini S, Barthélemy NR, Aschenbrenner AJ, Henson RL, Herries EM, Volluz K, Kirmess K, Eastwood S, Meyer M, Heller M, Jarrett L, et al. Timing of Biomarker Changes in Sporadic Alzheimer's Disease in Estimated Years from Symptom Onset. Annals of Neurology. PMID 38400792 DOI: 10.1002/ana.26891 |
0.699 |
|
| 2024 |
Wang G, Li Y, Xiong C, Benzinger TLS, Gordon BA, Hassenstab J, Aschenbrenner AJ, McDade E, Clifford DB, Libre-Guerra JJ, Shi X, Mummery CJ, van Dyck CH, Lah JJ, Honig LS, et al. Examining amyloid reduction as a surrogate endpoint through latent class analysis using clinical trial data for dominantly inherited Alzheimer's disease. Alzheimer's & Dementia : the Journal of the Alzheimer's Association. PMID 38400532 DOI: 10.1002/alz.13735 |
0.62 |
|
| 2024 |
Barthélemy NR, Salvadó G, Schindler S, He Y, Janelidze S, Collij LE, Saef B, Henson RL, Chen CD, Gordon BA, Li Y, La Joie R, Benzinger TLS, Morris JC, Mattsson-Carlgren N, et al. Highly Accurate Blood Test for Alzheimer's Disease Comparable or Superior to Clinical CSF Tests. Nature Medicine. PMID 38382645 DOI: 10.1038/s41591-024-02869-z |
0.719 |
|
| 2024 |
Joseph-Mathurin N, Feldman RL, Lu R, Shirzadi Z, Toomer C, Saint Clair JR, Ma Y, McKay NS, Strain JF, Kilgore C, Friedrichsen KA, Chen CD, Gordon BA, Chen G, Hornbeck RC, et al. Presenilin-1 mutation position influences amyloidosis, small vessel disease, and dementia with disease stage. Alzheimer's & Dementia : the Journal of the Alzheimer's Association. PMID 38380882 DOI: 10.1002/alz.13729 |
0.674 |
|
| 2024 |
Welhaf MS, Wilks H, Aschenbrenner AJ, Balota DA, Schindler SE, Benzinger TLS, Gordon BA, Cruchaga C, Xiong C, Morris JC, Hassenstab J. Naturalistic assessment of reaction time variability in older adults at risk for Alzheimer's disease. Journal of the International Neuropsychological Society : Jins. 1-11. PMID 38282413 DOI: 10.1017/S1355617723011475 |
0.723 |
|
| 2024 |
Shen Y, Ali M, Timsina J, Wang C, Do A, Western D, Liu M, Gorijala P, Budde J, Liu H, Gordon B, McDade E, Morris JC, Llibre-Guerra JJ, Bateman RJ, et al. Systematic proteomics in Autosomal dominant Alzheimer's disease reveals decades-early changes of CSF proteins in neuronal death, and immune pathways. Medrxiv : the Preprint Server For Health Sciences. PMID 38260583 DOI: 10.1101/2024.01.12.24301242 |
0.601 |
|
| 2023 |
Chen G, McKay NS, Gordon BA, Liu J, Joseph-Mathurin N, Schindler SE, Hassenstab J, Aschenbrenner AJ, Wang Q, Schultz SA, Su Y, LaMontagne PJ, Keefe SJ, Massoumzadeh P, Cruchaga C, et al. Predicting cognitive decline: Which is more useful, baseline amyloid levels or longitudinal change? Neuroimage. Clinical. 41: 103551. PMID 38150745 DOI: 10.1016/j.nicl.2023.103551 |
0.613 |
|
| 2023 |
Millar PR, Gordon BA, Wisch JK, Schultz SA, Benzinger TL, Cruchaga C, Hassenstab JJ, Ibanez L, Karch C, Llibre-Guerra JJ, Morris JC, Perrin RJ, Supnet-Bell C, Xiong C, Allegri RF, et al. Advanced structural brain aging in preclinical autosomal dominant Alzheimer disease. Molecular Neurodegeneration. 18: 98. PMID 38111006 DOI: 10.1186/s13024-023-00688-3 |
0.688 |
|
| 2023 |
Tu JC, Millar PR, Strain JF, Eck A, Adeyemo B, Daniels A, Karch C, Huey ED, McDade E, Day GS, Yakushev I, Hassenstab J, Morris J, Llibre-Guerra JJ, Ibanez L, ... ... Gordon BA, et al. Increasing hub disruption parallels dementia severity in autosomal dominant Alzheimer disease. Biorxiv : the Preprint Server For Biology. PMID 37961586 DOI: 10.1101/2023.10.29.564633 |
0.617 |
|
| 2023 |
Llibre-Guerra JJ, Iaccarino L, Coble D, Edwards L, Li Y, McDade E, Strom A, Gordon B, Mundada N, Schindler SE, Tsoy E, Ma Y, Lu R, Fagan AM, Benzinger TLS, et al. Longitudinal clinical, cognitive and biomarker profiles in dominantly inherited versus sporadic early-onset Alzheimer's disease. Brain Communications. 5: fcad280. PMID 37942088 DOI: 10.1093/braincomms/fcad280 |
0.718 |
|
| 2023 |
Rahmani F, Brier MR, Gordon BA, McKay N, Flores S, Keefe S, Hornbeck R, Ances B, Joseph-Mathurin N, Xiong C, Wang G, Raji CA, Libre-Guerra JJ, Perrin RJ, McDade E, et al. T1 and FLAIR signal intensities are related to tau pathology in dominantly inherited Alzheimer disease. Human Brain Mapping. PMID 37867465 DOI: 10.1002/hbm.26514 |
0.679 |
|
| 2023 |
Shirzadi Z, Schultz SA, Yau WW, Joseph-Mathurin N, Fitzpatrick CD, Levin R, Kantarci K, Preboske GM, Jack CR, Farlow MR, Hassenstab J, Jucker M, Morris JC, Xiong C, Karch CM, ... ... Gordon BA, et al. Etiology of White Matter Hyperintensities in Autosomal Dominant and Sporadic Alzheimer Disease. Jama Neurology. PMID 37843849 DOI: 10.1001/jamaneurol.2023.3618 |
0.705 |
|
| 2023 |
Wagemann O, Li Y, Hassenstab J, Aschenbrenner AJ, McKay NS, Gordon BA, Benzinger TLS, Xiong C, Cruchaga C, Renton AE, Perrin RJ, Berman SB, Chhatwal JP, Farlow MR, Day GS, et al. Investigation of sex differences in mutation carriers of the Dominantly Inherited Alzheimer Network. Alzheimer's & Dementia : the Journal of the Alzheimer's Association. PMID 37740921 DOI: 10.1002/alz.13460 |
0.703 |
|
| 2023 |
Johnson ECB, Bian S, Haque RU, Carter EK, Watson CM, Gordon BA, Ping L, Duong DM, Epstein MP, McDade E, Barthélemy NR, Karch CM, Xiong C, Cruchaga C, Perrin RJ, et al. Cerebrospinal fluid proteomics define the natural history of autosomal dominant Alzheimer's disease. Nature Medicine. PMID 37550416 DOI: 10.1038/s41591-023-02476-4 |
0.721 |
|
| 2023 |
Salvadó G, Horie K, Barthélemy NR, Vogel JW, Binette AP, Chen CD, Aschenbrenner AJ, Gordon BA, Benzinger TLS, Holtzman DM, Morris JC, Palmqvist S, Stomrud E, Janelidze S, Ossenkoppele R, et al. Novel CSF tau biomarkers can be used for disease staging of sporadic Alzheimer's disease. Medrxiv : the Preprint Server For Health Sciences. PMID 37503281 DOI: 10.1101/2023.07.14.23292650 |
0.724 |
|
| 2023 |
Horie K, Salvadó G, Barthélemy NR, Janelidze S, Li Y, He Y, Saef B, Chen CD, Jiang H, Strandberg O, Pichet Binette A, Palmqvist S, Sato C, Sachdev P, Koyama A, ... Gordon BA, et al. CSF MTBR-tau243 is a specific biomarker of tau tangle pathology in Alzheimer's disease. Nature Medicine. PMID 37443334 DOI: 10.1038/s41591-023-02443-z |
0.698 |
|
| 2023 |
McKay NS, Gordon BA, Hornbeck RC, Dincer A, Flores S, Keefe SJ, Joseph-Mathurin N, Jack CR, Koeppe R, Millar PR, Ances BM, Chen CD, Daniels A, Hobbs DA, Jackson K, et al. Positron emission tomography and magnetic resonance imaging methods and datasets within the Dominantly Inherited Alzheimer Network (DIAN). Nature Neuroscience. PMID 37429916 DOI: 10.1038/s41593-023-01359-8 |
0.7 |
|
| 2023 |
Schultz SA, Shirzadi Z, Schultz AP, Liu L, Fitzpatrick CD, McDade E, Barthelemy NR, Renton A, Esposito B, Joseph-Mathurin N, Cruchaga C, Chen CD, Goate A, Allegri RF, Benzinger TLS, ... ... Gordon BA, et al. Location of pathogenic variants in PSEN1 impacts progression of cognitive, clinical, and neurodegenerative measures in autosomal-dominant Alzheimer's disease. Aging Cell. e13871. PMID 37291760 DOI: 10.1111/acel.13871 |
0.706 |
|
| 2023 |
O'Connor A, Cash DM, Poole T, Markiewicz PJ, Fraser MR, Malone IB, Jiao J, Weston PSJ, Flores S, Hornbeck R, McDade E, Schöll M, Gordon BA, Bateman RJ, Benzinger TLS, et al. Tau accumulation in autosomal dominant Alzheimer's disease: a longitudinal [F]flortaucipir study. Alzheimer's Research & Therapy. 15: 99. PMID 37231491 DOI: 10.1186/s13195-023-01234-5 |
0.686 |
|
| 2023 |
Luo J, Ma Y, Agboola FJ, Grant E, Morris JC, McDade E, Fagan AM, Benzinger TLS, Hassenstab J, Bateman RJ, Perrin RJ, Gordon BA, Goyal M, Strain JF, Yakushev I, et al. Longitudinal Relationships of White Matter Hyperintensities and Alzheimer Disease Biomarkers Across the Adult Lifespan. Neurology. PMID 37202169 DOI: 10.1212/WNL.0000000000207378 |
0.734 |
|
| 2023 |
Barthélemy NR, Saef B, Li Y, Gordon BA, He Y, Horie K, Stomrud E, Salvadó G, Janelidze S, Sato C, Ovod V, Henson RL, Fagan AM, Benzinger TLS, Xiong C, et al. CSF tau phosphorylation occupancies at T217 and T205 represent improved biomarkers of amyloid and tau pathology in Alzheimer's disease. Nature Aging. 3: 391-401. PMID 37117788 DOI: 10.1038/s43587-023-00380-7 |
0.703 |
|
| 2023 |
Ali M, Archer DB, Gorijala P, Western D, Timsina J, Fernández MV, Wang TC, Satizabal CL, Yang Q, Beiser AS, Wang R, Chen G, Gordon B, Benzinger TLS, Xiong C, et al. Large multi-ethnic genetic analyses of amyloid imaging identify new genes for Alzheimer disease. Acta Neuropathologica Communications. 11: 68. PMID 37101235 DOI: 10.1186/s40478-023-01563-4 |
0.648 |
|
| 2023 |
Xu Y, Aung HL, Bateman RJ, Brooks WS, Chhatwal J, Day GS, Fagan AM, Farlow MR, Gordon B, Kehoe PG, Levin J, Mori H, Morris JC, Wharton W, Humburg P, et al. Higher systolic blood pressure in early-mid adulthood is associated with poorer cognitive performance in those with a dominantly inherited Alzheimer's disease mutation but not in non-carriers. Results from the DIAN study. Alzheimer's & Dementia : the Journal of the Alzheimer's Association. PMID 37087693 DOI: 10.1002/alz.13082 |
0.59 |
|
| 2023 |
Grober E, Petersen KK, Lipton RB, Hassenstab J, Morris JC, Gordon BA, Ezzati A. Association of Stages of Objective Memory Impairment With Incident Symptomatic Cognitive Impairment in Cognitively Normal Individuals. Neurology. PMID 37076305 DOI: 10.1212/WNL.0000000000207276 |
0.382 |
|
| 2023 |
Gorelik AJ, Paul SE, Karcher NR, Johnson EC, Nagella I, Blaydon L, Modi H, Hansen IS, Colbert SMC, Baranger DAA, Norton SA, Spears I, Gordon B, Zhang W, Hill PL, et al. A Phenome-Wide Association Study (PheWAS) of Late Onset Alzheimer Disease Genetic Risk in Children of European Ancestry at Middle Childhood: Results from the ABCD Study. Behavior Genetics. PMID 37071275 DOI: 10.1007/s10519-023-10140-3 |
0.34 |
|
| 2023 |
Chen CD, McCullough A, Gordon B, Joseph-Mathurin N, Flores S, McKay NS, Hobbs DA, Hornbeck R, Fagan AM, Cruchaga C, Goate AM, Perrin RJ, Wang G, Li Y, Shi X, et al. Longitudinal head-to-head comparison of C-PiB and F-florbetapir PET in a Phase 2/3 clinical trial of anti-amyloid-β monoclonal antibodies in dominantly inherited Alzheimer's disease. European Journal of Nuclear Medicine and Molecular Imaging. PMID 37017737 DOI: 10.1007/s00259-023-06209-0 |
0.628 |
|
| 2023 |
Wisch JK, Gordon BA, Boerwinkle AH, Luckett PH, Bollinger JG, Ovod V, Li Y, Henson RL, West T, Meyer MR, Kirmess KM, Benzinger TLS, Fagan AM, Morris JC, Bateman RJ, et al. Predicting continuous amyloid PET values with CSF and plasma Aβ42/Aβ40. Alzheimer's & Dementia (Amsterdam, Netherlands). 15: e12405. PMID 36874595 DOI: 10.1002/dad2.12405 |
0.696 |
|
| 2023 |
Horie K, Li Y, Barthélemy NR, Gordon BA, Hassenstab J, Benzinger TLS, Fagan AM, Morris JC, Karch CM, Xiong C, Allegri R, Mendez PC, Ikeuchi T, Kasuga K, Noble J, et al. Change in cerebrospinal fluid tau microtubule binding region detects symptom onset, cognitive decline, tangles, and atrophy in Dominantly Inherited Alzheimer's Disease. Annals of Neurology. PMID 36843330 DOI: 10.1002/ana.26620 |
0.718 |
|
| 2023 |
Xiong C, McCue LM, Buckles V, Grant E, Agboola F, Coble D, Bateman RJ, Fagan AM, Benzinger TLS, Hassenstab J, Schindler SE, McDade E, Moulder K, Gordon BA, Cruchaga C, et al. Cross-sectional and longitudinal comparisons of biomarkers and cognition among asymptomatic middle-aged individuals with a parental history of either autosomal dominant or late-onset Alzheimer's disease. Alzheimer's & Dementia : the Journal of the Alzheimer's Association. PMID 36640138 DOI: 10.1002/alz.12912 |
0.713 |
|
| 2023 |
Wheelock MD, Strain JF, Mansfield P, Tu JC, Tanenbaum A, Preische O, Chhatwal JP, Cash DM, Cruchaga C, Fagan AM, Fox NC, Graff-Radford NR, Hassenstab J, Jack CR, Karch CM, ... ... Gordon BA, et al. Brain network decoupling with increased serum neurofilament and reduced cognitive function in Alzheimer's disease. Brain : a Journal of Neurology. PMID 36625756 DOI: 10.1093/brain/awac498 |
0.545 |
|
| 2023 |
Millar PR, Gordon BA, Luckett PH, Benzinger TLS, Cruchaga C, Fagan AM, Hassenstab J, Perrin RJ, Schindler SE, Allegri RF, Day GS, Farlow MR, Mori H, Nübling G, Bateman RJ, et al. Multimodal brain age estimates relate to Alzheimer disease biomarkers and cognition in early stages: a cross-sectional observational study. Elife. 12. PMID 36607335 DOI: 10.7554/eLife.81869 |
0.698 |
|
| 2022 |
Chatterjee P, Vermunt L, Gordon BA, Pedrini S, Boonkamp L, Armstrong NJ, Xiong C, Singh AK, Li Y, Sohrabi HR, Taddei K, Molloy M, Benzinger TLS, Morris JC, Karch C, et al. Plasma glial fibrillary acidic protein in autosomal dominant Alzheimer's disease: Associations with Aβ-PET, neurodegeneration, and cognition. Alzheimer's & Dementia : the Journal of the Alzheimer's Association. PMID 36576155 DOI: 10.1002/alz.12879 |
0.716 |
|
| 2022 |
Wisch JK, Butt OH, Gordon BA, Schindler SE, Fagan AM, Henson RL, Yang C, Boerwinkle AH, Benzinger TLS, Holtzman DM, Morris JC, Cruchaga C, Ances BM. Proteomic clusters underlie heterogeneity in preclinical Alzheimer's disease progression. Brain : a Journal of Neurology. PMID 36542469 DOI: 10.1093/brain/awac484 |
0.667 |
|
| 2022 |
O'Connor A, Rice H, Barnes J, Ryan NS, Liu KY, Allegri RF, Berman S, Ringman JM, Cruchaga C, Farlow MR, Hassenstab J, Lee JH, Perrin RJ, Xiong C, Gordon B, et al. First presentation with neuropsychiatric symptoms in autosomal dominant Alzheimer's disease: the Dominantly Inherited Alzheimer's Network Study. Journal of Neurology, Neurosurgery, and Psychiatry. PMID 36522155 DOI: 10.1136/jnnp-2022-329843 |
0.681 |
|
| 2022 |
Boerwinkle AH, Gordon BA, Wisch J, Flores S, Henson RL, Butt OH, McKay N, Chen CD, Benzinger TLS, Fagan AM, Handen BL, Christian BT, Head E, Mapstone M, Rafii MS, et al. Comparison of amyloid burden in individuals with Down syndrome versus autosomal dominant Alzheimer's disease: a cross-sectional study. The Lancet. Neurology. 22: 55-65. PMID 36517172 DOI: 10.1016/S1474-4422(22)00408-2 |
0.676 |
|
| 2022 |
Dincer A, Chen CD, McKay NS, Koenig LN, McCullough A, Flores S, Keefe SJ, Schultz SA, Feldman RL, Joseph-Mathurin N, Hornbeck RC, Cruchaga C, Schindler SE, Holtzman DM, Morris JC, ... ... Gordon BA, et al. APOE ε4 genotype, amyloid-β, and sex interact to predict tau in regions of high APOE mRNA expression. Science Translational Medicine. 14: eabl7646. PMID 36383681 DOI: 10.1126/scitranslmed.abl7646 |
0.569 |
|
| 2022 |
Wang G, Li Y, Xiong C, McDade E, Clifford DB, Mills SL, Santacruz AM, Aschenbrenner AJ, Hassenstab J, Benzinger TLS, Gordon BA, Fagan AM, Coalier KA, Libre-Guerra JJ, McCullough A, et al. Evaluation of dose-dependent treatment effects after mid-trial dose escalation in biomarker, clinical, and cognitive outcomes for gantenerumab or solanezumab in dominantly inherited Alzheimer's disease. Alzheimer's & Dementia (Amsterdam, Netherlands). 14: e12367. PMID 36348972 DOI: 10.1002/dad2.12367 |
0.556 |
|
| 2022 |
Warren-Gash C, Cadogan SL, Nicholas JM, Breuer JM, Shah D, Pearce N, Shiekh S, Smeeth L, Farlow MR, Mori H, Gordon BA, Nuebling G, McDade E, Bateman RJ, Schofield PR, et al. Herpes simplex virus and rates of cognitive decline or whole brain atrophy in the Dominantly Inherited Alzheimer Network. Annals of Clinical and Translational Neurology. PMID 36189728 DOI: 10.1002/acn3.51669 |
0.547 |
|
| 2022 |
Hartz SM, Mozersky J, Schindler SE, Linnenbringer E, Wang J, Gordon BA, Raji CA, Moulder KL, West T, Benzinger TLS, Cruchaga C, Hassenstab JJ, Bierut LJ, Xiong C, Morris JC. A flexible modeling approach for biomarker-based computation of absolute risk of Alzheimer's disease dementia. Alzheimer's & Dementia : the Journal of the Alzheimer's Association. PMID 36178120 DOI: 10.1002/alz.12781 |
0.631 |
|
| 2022 |
Joseph-Mathurin N, Llibre-Guerra JJ, Li Y, McCullough AA, Hofmann C, Wojtowicz J, Park E, Wang G, Preboske GM, Wang Q, Gordon BA, Chen CD, Flores S, Aggarwal NT, Berman SB, et al. Amyloid-related imaging abnormalities in the DIAN-TU-001 trial of gantenerumab and solanezumab: lessons from a trial in dominantly inherited Alzheimer disease. Annals of Neurology. PMID 36151869 DOI: 10.1002/ana.26511 |
0.641 |
|
| 2022 |
Nicosia J, Aschenbrenner AJ, Balota DA, Sliwinski MJ, Tahan M, Adams S, Stout SS, Wilks H, Gordon BA, Benzinger TLS, Fagan AM, Xiong C, Bateman RJ, Morris JC, Hassenstab J. Unsupervised high-frequency smartphone-based cognitive assessments are reliable, valid, and feasible in older adults at risk for Alzheimer's disease. Journal of the International Neuropsychological Society : Jins. 1-13. PMID 36062528 DOI: 10.1017/S135561772200042X |
0.813 |
|
| 2022 |
Flores S, Chen CD, Su Y, Dincer A, Keefe SJ, McKay NS, Paulick AM, Perez-Carillo GG, Wang L, Hornbeck RC, Goyal M, Vlassenko A, Schwarz S, Nickels ML, Wong DF, ... ... Gordon BA, et al. Investigating Tau and Amyloid Tracer Skull Binding in Studies of Alzheimer disease. Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine. PMID 35953305 DOI: 10.2967/jnumed.122.263948 |
0.547 |
|
| 2022 |
Luo J, Agboola F, Grant E, Morris JC, Masters CL, Albert MS, Johnson SC, McDade EM, Fagan AM, Benzinger TLS, Hassenstab J, Bateman RJ, Perrin RJ, Wang G, Li Y, ... Gordon B, et al. Accelerated longitudinal changes and ordering of Alzheimer disease biomarkers across the adult lifespan. Brain : a Journal of Neurology. PMID 35925685 DOI: 10.1093/brain/awac238 |
0.729 |
|
| 2022 |
Strain JF, Brier MR, Tanenbaum A, Gordon BA, McCarthy JE, Dincer A, Marcus DS, Chhatwal JP, Graff-Radford NR, Day GS, la Fougère C, Perrin RJ, Salloway S, Schofield PR, Yakushev I, et al. Covariance-based vs. Correlation-based Functional Connectivity Dissociates Healthy Aging from Alzheimer Disease. Neuroimage. 119511. PMID 35914670 DOI: 10.1016/j.neuroimage.2022.119511 |
0.674 |
|
| 2022 |
Strikwerda-Brown C, Hobbs DA, Gonneaud J, St-Onge F, Binette AP, Ozlen H, Provost K, Soucy JP, Buckley RF, Benzinger TLS, Morris JC, Villemagne VL, Doré V, Sperling RA, Johnson KA, ... ... Gordon BA, et al. Association of Elevated Amyloid and Tau Positron Emission Tomography Signal With Near-Term Development of Alzheimer Disease Symptoms in Older Adults Without Cognitive Impairment. Jama Neurology. PMID 35907254 DOI: 10.1001/jamaneurol.2022.2379 |
0.666 |
|
| 2022 |
Long JM, Coble DW, Xiong C, Schindler SE, Perrin RJ, Gordon BA, Benzinger TLS, Grant E, Fagan AM, Harari O, Cruchaga C, Holtzman DM, Morris JC. Preclinical Alzheimer's disease biomarkers accurately predict cognitive and neuropathological outcomes. Brain : a Journal of Neurology. PMID 35867858 DOI: 10.1093/brain/awac250 |
0.672 |
|
| 2022 |
Levitis E, Vogel JW, Funck T, Hachinski V, Gauthier S, Vöglein J, Levin J, Gordon BA, Benzinger T, Iturria-Medina Y, Evans AC. Differentiating amyloid beta spread in autosomal dominant and sporadic Alzheimer's disease. Brain Communications. 4: fcac085. PMID 35602652 DOI: 10.1093/braincomms/fcac085 |
0.548 |
|
| 2022 |
Morris JC, Weiner M, Xiong C, Beckett L, Coble D, Saito N, Aisen PS, Allegri R, Benzinger TLS, Berman SB, Cairns NJ, Carrillo MC, Chui HC, Chhatwal JP, Cruchaga C, ... ... Gordon BA, et al. Autosomal dominant and sporadic late onset Alzheimer disease share a common in vivo pathophysiology. Brain : a Journal of Neurology. PMID 35580594 DOI: 10.1093/brain/awac181 |
0.748 |
|
| 2022 |
Millar PR, Luckett PH, Gordon BA, Benzinger TL, Schindler SE, Fagan AM, Cruchaga C, Bateman RJ, Allegri R, Jucker M, Lee JH, Mori H, Salloway SP, Yakushev I, Morris JC, et al. Predicting brain age from functional connectivity in symptomatic and preclinical Alzheimer disease. Neuroimage. 119228. PMID 35452806 DOI: 10.1016/j.neuroimage.2022.119228 |
0.695 |
|
| 2022 |
Schindler SE, Karikari TK, Ashton NJ, Henson RL, Yarasheski KE, West T, Meyer MR, Kirmess KM, Li Y, Saef B, Moulder KL, Bradford D, Fagan AM, Gordon BA, Benzinger TLS, et al. Effect of Race on Prediction of Brain Amyloidosis by Plasma Aβ42/Aβ40, Phosphorylated Tau, and Neurofilament Light. Neurology. PMID 35450967 DOI: 10.1212/WNL.0000000000200358 |
0.671 |
|
| 2022 |
Luckett PH, Chen C, Gordon BA, Wisch J, Berman SB, Chhatwal JP, Cruchaga C, Fagan AM, Farlow MR, Fox NC, Jucker M, Levin J, Masters CL, Mori H, Noble JM, et al. Biomarker clustering in autosomal dominant Alzheimer's disease. Alzheimer's & Dementia : the Journal of the Alzheimer's Association. PMID 35362200 DOI: 10.1002/alz.12661 |
0.703 |
|
| 2022 |
Strain JF, Barthelemy N, Horie K, Gordon BA, Kilgore C, Aschenbrenner A, Cruchaga C, Xiong C, Joseph-Mathurin N, Hassenstab J, Fagan AM, Li Y, Karch CM, Perrin RJ, Berman SB, et al. CSF Tau phosphorylation at Thr205 is associated with loss of white matter integrity in autosomal dominant Alzheimer disease. Neurobiology of Disease. 168: 105714. PMID 35358703 DOI: 10.1016/j.nbd.2022.105714 |
0.706 |
|
| 2022 |
Morenas-Rodríguez E, Li Y, Nuscher B, Franzmeier N, Xiong C, Suárez-Calvet M, Fagan AM, Schultz S, Gordon BA, Benzinger TLS, Hassenstab J, McDade E, Feederle R, Karch CM, Schlepckow K, et al. Soluble TREM2 in CSF and its association with other biomarkers and cognition in autosomal-dominant Alzheimer's disease: a longitudinal observational study. The Lancet. Neurology. 21: 329-341. PMID 35305339 DOI: 10.1016/S1474-4422(22)00027-8 |
0.745 |
|
| 2022 |
McKay NS, Dincer A, Mehrotra V, Aschenbrenner AJ, Balota D, Hornbeck RC, Hassenstab J, Morris JC, Benzinger TLS, Gordon BA. Beta-amyloid moderates the relationship between cortical thickness and attentional control in middle- and older-aged adults. Neurobiology of Aging. 112: 181-190. PMID 35227946 DOI: 10.1016/j.neurobiolaging.2021.12.012 |
0.718 |
|
| 2022 |
Meeker KL, Butt OH, Gordon BA, Fagan AM, Schindler SE, Morris JC, Benzinger TLS, Ances BM. Cerebrospinal fluid neurofilament light chain is a marker of aging and white matter damage. Neurobiology of Disease. 105662. PMID 35167933 DOI: 10.1016/j.nbd.2022.105662 |
0.591 |
|
| 2022 |
Chhatwal JP, Schultz SA, McDade E, Schultz AP, Liu L, Hanseeuw BJ, Joseph-Mathurin N, Feldman R, Fitzpatrick CD, Sparks KP, Levin J, Berman SB, Renton AE, Esposito BT, Fernandez MV, ... ... Gordon BA, et al. Variant-dependent heterogeneity in amyloid β burden in autosomal dominant Alzheimer's disease: cross-sectional and longitudinal analyses of an observational study. The Lancet. Neurology. 21: 140-152. PMID 35065037 DOI: 10.1016/S1474-4422(21)00375-6 |
0.719 |
|
| 2022 |
Wilks H, Aschenbrenner AJ, Gordon BA, Balota DA, Fagan AM, Musiek E, Balls-Berry J, Benzinger TLS, Cruchaga C, Morris JC, Hassenstab J. Sharper in the morning: Cognitive time of day effects revealed with high-frequency smartphone testing. Journal of Clinical and Experimental Neuropsychology. 1-13. PMID 35037593 DOI: 10.1080/13803395.2021.2009447 |
0.708 |
|
| 2021 |
Koenig LN, LaMontagne P, Glasser MF, Bateman R, Holtzman D, Yakushev I, Chhatwal J, Day GS, Jack C, Mummery C, Perrin RJ, Gordon BA, Morris JC, Shimony JS, Benzinger TLS, et al. Regional age-related atrophy after screening for preclinical alzheimer disease. Neurobiology of Aging. 109: 43-51. PMID 34655980 DOI: 10.1016/j.neurobiolaging.2021.09.010 |
0.661 |
|
| 2021 |
Hassenstab J, Nicosia J, LaRose M, Aschenbrenner AJ, Gordon BA, Benzinger TLS, Xiong C, Morris JC. Is comprehensiveness critical? Comparing short and long format cognitive assessments in preclinical Alzheimer disease. Alzheimer's Research & Therapy. 13: 153. PMID 34517889 DOI: 10.1186/s13195-021-00894-5 |
0.8 |
|
| 2021 |
Gonneaud J, Baria AT, Pichet Binette A, Gordon BA, Chhatwal JP, Cruchaga C, Jucker M, Levin J, Salloway S, Farlow M, Gauthier S, Benzinger TLS, Morris JC, Bateman RJ, Breitner JCS, et al. Accelerated functional brain aging in pre-clinical familial Alzheimer's disease. Nature Communications. 12: 5346. PMID 34504080 DOI: 10.1038/s41467-021-25492-9 |
0.713 |
|
| 2021 |
Schindler S, Li Y, Buckles VD, Gordon BA, Benzinger TLS, Wang G, Coble D, Klunk WE, Fagan AM, Holtzman D, Bateman RJ, Morris JC, Xiong C. Predicting Symptom Onset in Sporadic Alzheimer Disease With Amyloid PET. Neurology. PMID 34504028 DOI: 10.1212/WNL.0000000000012775 |
0.714 |
|
| 2021 |
Chen CD, Joseph-Mathurin N, Sinha N, Zhou A, Li Y, Friedrichsen K, McCullough A, Franklin EE, Hornbeck R, Gordon B, Sharma V, Cruchaga C, Goate A, Karch C, McDade E, et al. Comparing amyloid-β plaque burden with antemortem PiB PET in autosomal dominant and late-onset Alzheimer disease. Acta Neuropathologica. PMID 34319442 DOI: 10.1007/s00401-021-02342-y |
0.66 |
|
| 2021 |
Keret O, Staffaroni AM, Ringman JM, Cobigo Y, Goh SM, Wolf A, Allen IE, Salloway S, Chhatwal J, Brickman AM, Reyes-Dumeyer D, Bateman RJ, Benzinger TLS, Morris JC, Ances BM, ... ... Gordon BA, et al. Pattern and degree of individual brain atrophy predicts dementia onset in dominantly inherited Alzheimer's disease. Alzheimer's & Dementia (Amsterdam, Netherlands). 13: e12197. PMID 34258377 DOI: 10.1002/dad2.12197 |
0.657 |
|
| 2021 |
Salloway S, Farlow M, McDade E, Clifford DB, Wang G, Llibre-Guerra JJ, Hitchcock JM, Mills SL, Santacruz AM, Aschenbrenner AJ, Hassenstab J, Benzinger TLS, Gordon BA, Fagan AM, Coalier KA, et al. A trial of gantenerumab or solanezumab in dominantly inherited Alzheimer's disease. Nature Medicine. PMID 34155411 DOI: 10.1038/s41591-021-01369-8 |
0.689 |
|
| 2021 |
Harrington KD, Aschenbrenner AJ, Maruff P, Masters CL, Fagan AM, Benzinger TLS, Gordon BA, Cruchaga C, Morris JC, Hassenstab J. Undetected Neurodegenerative Disease Biases Estimates of Cognitive Change in Older Adults. Psychological Science. 956797620985518. PMID 34043464 DOI: 10.1177/0956797620985518 |
0.578 |
|
| 2021 |
Boerwinkle AH, Wisch JK, Chen CD, Gordon BA, Butt OH, Schindler SE, Sutphen C, Flores S, Dincer A, Benzinger TLS, Fagan AM, Morris JC, Ances BM. Temporal Correlation of CSF and Neuroimaging in the Amyloid-Tau-Neurodegeneration Model of Alzheimer Disease. Neurology. PMID 33931538 DOI: 10.1212/WNL.0000000000012123 |
0.662 |
|
| 2021 |
Ewers M, Luan Y, Frontzkowski L, Neitzel J, Rubinski A, Dichgans M, Hassenstab J, Gordon BA, Chhatwal JP, Levin J, Schofield P, Benzinger TLS, Morris JC, Goate A, Karch CM, et al. Segregation of functional networks is associated with cognitive resilience in Alzheimer's disease. Brain : a Journal of Neurology. PMID 33725114 DOI: 10.1093/brain/awab112 |
0.72 |
|
| 2021 |
Joseph-Mathurin N, Wang G, Kantarci K, Jack CR, McDade E, Hassenstab J, Blazey TM, Gordon BA, Su Y, Chen G, Massoumzadeh P, Hornbeck RC, Allegri RF, Ances BM, Berman SB, et al. Longitudinal Accumulation of Cerebral Microhemorrhages in Dominantly Inherited Alzheimer Disease. Neurology. PMID 33495373 DOI: 10.1212/WNL.0000000000011542 |
0.676 |
|
| 2021 |
Luckett PH, McCullough A, Gordon BA, Strain J, Flores S, Dincer A, McCarthy J, Kuffner T, Stern A, Meeker KL, Berman SB, Chhatwal JP, Cruchaga C, Fagan AM, Farlow MR, et al. Modeling autosomal dominant Alzheimer's disease with machine learning. Alzheimer's & Dementia : the Journal of the Alzheimer's Association. PMID 33480178 DOI: 10.1002/alz.12259 |
0.642 |
|
| 2021 |
Smith R, Strain J, Tanenbaum A, Fagan A, Hassenstab J, Mcdade E, Schindler S, Gordon B, Xiong C, Chhatwal J, Jack CR, Karch C, Berman S, Brosch J, Lah J, et al. Resting-State Functional Connectivity Disruption as a Pathological Biomarker in Autosomal Dominant Alzheimer Disease. Brain Connectivity. PMID 33430685 DOI: 10.1089/brain.2020.0808 |
0.682 |
|
| 2021 |
Day GS, Gordon BA, McCullough A, Bucelli RC, Perrin RJ, Benzinger TLS, Ances BM. Flortaucipir (tau) PET in LGI1 antibody encephalitis. Annals of Clinical and Translational Neurology. PMID 33410601 DOI: 10.1002/acn3.51297 |
0.537 |
|
| 2020 |
Dincer A, Gordon BA, Hari-Raj A, Keefe SJ, Flores S, McKay NS, Paulick AM, Shady Lewis KE, Feldman RL, Hornbeck RC, Allegri R, Ances BM, Berman SB, Brickman AM, Brooks WS, et al. Comparing cortical signatures of atrophy between late-onset and autosomal dominant Alzheimer disease. Neuroimage. Clinical. 28: 102491. PMID 33395982 DOI: 10.1016/j.nicl.2020.102491 |
0.601 |
|
| 2020 |
Meeker KL, Ances BM, Gordon BA, Rudolph CW, Luckett P, Balota DA, Morris JC, Fagan AM, Benzinger TL, Waring JD. Cerebrospinal fluid Aβ42 moderates the relationship between brain functional network dynamics and cognitive intraindividual variability. Neurobiology of Aging. 98: 116-123. PMID 33264709 DOI: 10.1016/j.neurobiolaging.2020.10.027 |
0.725 |
|
| 2020 |
Chen CD, Holden TR, Gordon BA, Franklin EE, Li Y, Coble DW, Luo H, Bateman RJ, Ances BM, Perrin RJ, Benzinger TLS, Cairns NJ, Morris JC. Ante- and postmortem tau in autosomal dominant and late-onset Alzheimer's disease. Annals of Clinical and Translational Neurology. PMID 33150749 DOI: 10.1002/acn3.51237 |
0.728 |
|
| 2020 |
Millar PR, Ances BM, Gordon BA, Benzinger TLS, Morris JC, Balota DA. Evaluating Cognitive Relationships with Resting-State and Task-driven Blood Oxygen Level-Dependent Variability. Journal of Cognitive Neuroscience. 1-24. PMID 33135966 DOI: 10.1162/jocn_a_01645 |
0.634 |
|
| 2020 |
Meeker KL, Wisch JK, Hudson D, Coble D, Xiong C, Babulal GM, Gordon BA, Schindler SE, Cruchaga C, Flores S, Dincer A, Benzinger TL, Morris JC, Ances BM. Socioeconomic Status Mediates Racial Differences Seen Using the AT(N) Framework. Annals of Neurology. PMID 33111990 DOI: 10.1002/ana.25948 |
0.607 |
|
| 2020 |
Millar PR, Ances BM, Gordon BA, Benzinger TLS, Fagan AM, Morris JC, Balota DA. Evaluating resting-state BOLD variability in relation to biomarkers of preclinical Alzheimer's disease. Neurobiology of Aging. 96: 233-245. PMID 33039901 DOI: 10.1016/J.Neurobiolaging.2020.08.007 |
0.743 |
|
| 2020 |
Goyal MS, Gordon BA, Couture LE, Flores S, Xiong C, Morris JC, Raichle ME, L-S Benzinger T, Vlassenko AG. Spatiotemporal relationship between subthreshold amyloid accumulation and aerobic glycolysis in the human brain. Neurobiology of Aging. 96: 165-175. PMID 33011615 DOI: 10.1016/J.Neurobiolaging.2020.08.019 |
0.534 |
|
| 2020 |
Vermunt L, Dicks E, Wang G, Dincer A, Flores S, Keefe SJ, Berman SB, Cash DM, Chhatwal JP, Cruchaga C, Fox NC, Ghetti B, Graff-Radford NR, Hassenstab J, Karch CM, ... ... Gordon BA, et al. Single-subject grey matter network trajectories over the disease course of autosomal dominant Alzheimer's disease. Brain Communications. 2: fcaa102. PMID 32954344 DOI: 10.1093/braincomms/fcaa102 |
0.683 |
|
| 2020 |
Mill RD, Gordon BA, Balota DA, Cole MW. Predicting dysfunctional age-related task activations from resting-state network alterations. Neuroimage. 221: 117167. PMID 32682094 DOI: 10.1016/J.Neuroimage.2020.117167 |
0.621 |
|
| 2020 |
Schultz SA, Strain JF, Adedokun A, Wang Q, Preische O, Kuhle J, Flores S, Keefe S, Dincer A, Ances BM, Berman SB, Brickman AM, Cash DM, Chhatwal J, Cruchaga C, ... ... Gordon BA, et al. Serum neurofilament light chain levels are associated with white matter integrity in autosomal dominant Alzheimer's disease. Neurobiology of Disease. 104960. PMID 32522711 DOI: 10.1016/J.Nbd.2020.104960 |
0.667 |
|
| 2020 |
Wisch JK, Meeker KL, Gordon BA, Flores S, Dincer A, Grant EA, Benzinger TL, Morris JC, Ances BM. Sex-related Differences in Tau Positron Emission Tomography (PET) and the Effects of Hormone Therapy (HT). Alzheimer Disease and Associated Disorders. PMID 32520734 DOI: 10.1097/Wad.0000000000000393 |
0.619 |
|
| 2020 |
Millar PR, Petersen SE, Ances BM, Gordon BA, Benzinger TLS, Morris JC, Balota DA. Evaluating the Sensitivity of Resting-State BOLD Variability to Age and Cognition after Controlling for Motion and Cardiovascular Influences: A Network-Based Approach. Cerebral Cortex (New York, N.Y. : 1991). PMID 32515824 DOI: 10.1093/Cercor/Bhaa138 |
0.673 |
|
| 2020 |
Quiroz YT, Zetterberg H, Reiman EM, Chen Y, Su Y, Fox-Fuller JT, Garcia G, Villegas A, Sepulveda-Falla D, Villada M, Arboleda-Velasquez JF, Guzmán-Vélez E, Vila-Castelar C, Gordon BA, Schultz SA, et al. Plasma neurofilament light chain in the presenilin 1 E280A autosomal dominant Alzheimer's disease kindred: a cross-sectional and longitudinal cohort study. The Lancet. Neurology. 19: 513-521. PMID 32470423 DOI: 10.1016/S1474-4422(20)30137-X |
0.388 |
|
| 2020 |
Koenig LN, Day GS, Salter A, Keefe S, Marple LM, Long J, LaMontagne P, Massoumazada P, Snider BJ, Kanthamneni M, Raji CA, Ghoshal N, Gordon BA, Miller-Thomas M, Morris JC, et al. Select Atrophied Regions in Alzheimer disease (SARA): An improved volumetric model for identifying Alzheimer disease dementia. Neuroimage. Clinical. 26: 102248. PMID 32334404 DOI: 10.1016/j.nicl.2020.102248 |
0.649 |
|
| 2020 |
Barthélemy NR, Li Y, Joseph-Mathurin N, Gordon BA, Hassenstab J, Benzinger TLS, Buckles V, Fagan AM, Perrin RJ, Goate AM, Morris JC, Karch CM, Xiong C, Allegri R, Mendez PC, et al. A soluble phosphorylated tau signature links tau, amyloid and the evolution of stages of dominantly inherited Alzheimer's disease. Nature Medicine. 26: 398-407. PMID 32161412 DOI: 10.1038/S41591-020-0781-Z |
0.734 |
|
| 2020 |
Gordon BA. Neurofilaments in disease: what do we know? Current Opinion in Neurobiology. 61: 105-115. PMID 32151970 DOI: 10.1016/J.Conb.2020.02.001 |
0.37 |
|
| 2020 |
Aschenbrenner AJ, Gordon BA, Fagan AM, Schindler SE, Balota DA, Morris JC, Hassenstab JJ. Neurofilament Light Predicts Decline in Attention but Not Episodic Memory in Preclinical Alzheimer's Disease. Journal of Alzheimer's Disease : Jad. PMID 32144992 DOI: 10.3233/Jad-200018 |
0.703 |
|
| 2020 |
Franzmeier N, Koutsouleris N, Benzinger T, Goate A, Karch CM, Fagan AM, McDade E, Duering M, Dichgans M, Levin J, Gordon BA, Lim YY, Masters CL, Rossor M, Fox NC, et al. Predicting sporadic Alzheimer's disease progression via inherited Alzheimer's disease-informed machine-learning. Alzheimer's & Dementia : the Journal of the Alzheimer's Association. PMID 32043733 DOI: 10.1002/Alz.12032 |
0.738 |
|
| 2020 |
Dincer A, Gordon BA, Hari-Raj A, Keefe SJ, Flores S, McKay NS, Paulick AM, Shady Lewis KE, Feldman RL, Hornbeck RC, Allegri R, Ances BM, Berman SB, Brickman AM, Brooks WS, et al. Comparing cortical signatures of atrophy between late-onset and autosomal dominant Alzheimer disease Neuroimage: Clinical. 28: 102491. DOI: 10.1016/j.nicl.2020.102491 |
0.358 |
|
| 2019 |
Llibre-Guerra JJ, Li Y, Schindler SE, Gordon BA, Fagan AM, Morris JC, Benzinger TLS, Hassenstab J, Wang G, Allegri R, Berman SB, Chhatwal J, Farlow MR, Holtzman DM, Jucker M, et al. Association of Longitudinal Changes in Cerebrospinal Fluid Total Tau and Phosphorylated Tau 181 and Brain Atrophy With Disease Progression in Patients With Alzheimer Disease. Jama Network Open. 2: e1917126. PMID 31825500 DOI: 10.1001/jamanetworkopen.2019.17126 |
0.697 |
|
| 2019 |
Gordon BA, Tijms BM. Elevated tau PET signal depends on abnormal amyloid levels and is uncommon in unimpaired individuals. Brain : a Journal of Neurology. 142: 2903-2904. PMID 31560059 DOI: 10.1093/Brain/Awz278 |
0.382 |
|
| 2019 |
Schultz SA, Gordon BA, Mishra S, Su Y, Morris JC, Ances BM, Duchek JM, Balota DA, Benzinger TLS. Association between personality and tau-PET binding in cognitively normal older adults. Brain Imaging and Behavior. PMID 31486975 DOI: 10.1007/S11682-019-00163-Y |
0.753 |
|
| 2019 |
Schindler SE, Bollinger JG, Ovod V, Mawuenyega KG, Li Y, Gordon BA, Holtzman DM, Morris JC, Benzinger TLS, Xiong C, Fagan AM, Bateman RJ. High-precision plasma β-amyloid 42/40 predicts current and future brain amyloidosis. Neurology. PMID 31371569 DOI: 10.1212/Wnl.0000000000008081 |
0.694 |
|
| 2019 |
Thirunavu V, McCullough A, Su Y, Flores S, Dincer A, Morris JC, Cruchaga C, Benzinger TLS, Gordon BA. Higher Body Mass Index Is Associated with Lower Cortical Amyloid-β Burden in Cognitively Normal Individuals in Late-Life. Journal of Alzheimer's Disease : Jad. PMID 31156169 DOI: 10.3233/Jad-190154 |
0.643 |
|
| 2019 |
Wang Q, Wang Y, Liu J, Sutphen CL, Cruchaga C, Blazey T, Gordon BA, Su Y, Chen C, Shimony JS, Ances BM, Cairns NJ, Fagan AM, Morris JC, Benzinger TLS. Quantification of white matter cellularity and damage in preclinical and early symptomatic Alzheimer's disease. Neuroimage. Clinical. 22: 101767. PMID 30901713 DOI: 10.1016/J.Nicl.2019.101767 |
0.656 |
|
| 2019 |
Franzmeier N, Ren J, Damm A, Monté-Rubio G, Boada M, Ruiz A, Ramirez A, Jessen F, Düzel E, Rodríguez Gómez O, Benzinger T, Goate A, Karch CM, Fagan AM, McDade E, ... ... Gordon BA, et al. The BDNF SNP modulates the association between beta-amyloid and hippocampal disconnection in Alzheimer's disease. Molecular Psychiatry. PMID 30899092 DOI: 10.1038/S41380-019-0404-6 |
0.73 |
|
| 2019 |
Su Y, Flores S, Wang G, Hornbeck RC, Speidel B, Joseph-Mathurin N, Vlassenko AG, Gordon BA, Koeppe RA, Klunk WE, Jack CR, Farlow MR, Salloway S, Snider BJ, Berman SB, et al. Comparison of Pittsburgh compound B and florbetapir in cross-sectional and longitudinal studies. Alzheimer's & Dementia (Amsterdam, Netherlands). 11: 180-190. PMID 30847382 DOI: 10.1016/J.Dadm.2018.12.008 |
0.651 |
|
| 2019 |
Ly CV, Koenig L, Christensen J, Gordon B, Beaumont H, Dahiya S, Chen J, Su Y, Nelson B, Jockel-Balsarotti J, Drain C, Jerome G, Morris JC, Fagan AM, Harms MB, et al. Tau positron emission tomography imaging in C9orf72 repeat expansion carriers. European Journal of Neurology. PMID 30790403 DOI: 10.1111/Ene.13940 |
0.454 |
|
| 2019 |
Gordon BA, Blazey TM, Christensen J, Dincer A, Flores S, Keefe S, Chen C, Su Y, McDade EM, Wang G, Li Y, Hassenstab J, Aschenbrenner A, Hornbeck R, Jack CR, et al. Tau PET in autosomal dominant Alzheimer's disease: relationship with cognition, dementia and other biomarkers. Brain : a Journal of Neurology. PMID 30753379 DOI: 10.1093/Brain/Awz019 |
0.761 |
|
| 2019 |
Preische O, Schultz SA, Apel A, Kuhle J, Kaeser SA, Barro C, Gräber S, Kuder-Buletta E, LaFougere C, Laske C, Vöglein J, Levin J, Masters CL, Martins R, Schofield PR, ... ... Gordon BA, et al. Serum neurofilament dynamics predicts neurodegeneration and clinical progression in presymptomatic Alzheimer's disease. Nature Medicine. PMID 30664784 DOI: 10.1038/S41591-018-0304-3 |
0.722 |
|
| 2019 |
Day GS, Gordon BA, Perrin RJ, Ances BM. Author response: In vivo [F]-AV-1451 tau-PET imaging in sporadic Creutzfeldt-Jakob disease. Neurology. 92: 150. PMID 30643031 DOI: 10.1212/Wnl.0000000000006771 |
0.445 |
|
| 2019 |
Morris JC, Schindler SE, McCue LM, Moulder KL, Benzinger TLS, Cruchaga C, Fagan AM, Grant E, Gordon BA, Holtzman DM, Xiong C. Assessment of Racial Disparities in Biomarkers for Alzheimer Disease. Jama Neurology. PMID 30615028 DOI: 10.1001/Jamaneurol.2018.4249 |
0.652 |
|
| 2019 |
Chen G, Gordon BA, Liu J, LaMontagne PJ, Keefe S, Dincer A, Morris JC, Benzinger TL. P1-246: BASELINE BIOMARKERS ARE MORE ACCURATE THAN LONGITUDINAL CHANGE OF BIOMARKERS IN PREDICTING COGNITIVE DECLINE Alzheimer's & Dementia. 15: P332-P333. DOI: 10.1016/J.Jalz.2019.06.801 |
0.446 |
|
| 2019 |
Strain JF, Wisch J, Kilgore CB, McDade E, Li Y, Barthélemy NR, Gordon BA, Hassenstab J, Fagan AM, Morris JC, Benzinger TLS, Bateman R, Ances BM, Dian. Ic‐P‐098: Phosphorylation Of Specific Tau Sites Is Associated With Loss Of White Matter Integrity In Autosomal Dominant Alzheimer Disease Alzheimers & Dementia. 15. DOI: 10.1016/J.Jalz.2019.06.4941 |
0.628 |
|
| 2019 |
Schultz SA, Adedokun A, Strain JF, Wang Q, Preische O, Kuhle J, Morris JC, Bateman R, Jucker M, Gordon BA, Benzinger TLS. Ic-P-094: Cross-Sectional And Longitudinal Association Between Serum Neurofilament Light And Established White Matter Neuroimaging Markers In Autosomal Dominant Alzheimer Disease Alzheimers & Dementia. 15. DOI: 10.1016/J.Jalz.2019.06.4937 |
0.599 |
|
| 2019 |
Dincer A, Gordon BA, Vlassenko AG, Goyal MS, Aschenbrenner AJ, McCullough AA, Adedokun A, Marple LM, Flores S, Keefe S, Chen G, Hornbeck RC, Morris JC, Benzinger TL. IC-P-090: COMPARISON OF ALZHEIMER'S DISEASE BIOMARKER MEASURES AS PREDICTORS OF COGNITION Alzheimer's & Dementia. 15: P80-P80. DOI: 10.1016/J.Jalz.2019.06.4933 |
0.535 |
|
| 2019 |
Schultz SA, Adedokun A, Strain JF, Wang Q, Preische O, Kuhle J, Morris JC, Bateman R, Jucker M, Gordon BA, Benzinger TLS. O3-12-01: Association Between Serum Neurofilament Light And Established White Matter Neuroimaging Markers In Autosomal Dominant Alzheimer Disease Alzheimers & Dementia. 15. DOI: 10.1016/J.Jalz.2019.06.4690 |
0.603 |
|
| 2019 |
Li Y, Schindler SE, Llibre Guerra JJ, Bollinger JG, Ovod V, Mawuenyega KG, Gordon BA, Holtzman DM, Morris JC, Benzinger TL, Xiong C, Fagan AM, Bateman R. PLASMA Aβ42/Aβ40 PREDICTS HIPPOCAMPAL ATROPHY Alzheimer's & Dementia. 15: P191-P192. DOI: 10.1016/J.Jalz.2019.06.4519 |
0.668 |
|
| 2019 |
Vermunt L, Tijms BM, Visser PJ, Scheltens P, Bateman R, Benzinger TLS, Gordon BA, Dian. O2-09-04: Single-Subject Grey Matter Networks Deteriorate 12 Years Before Dementia Alzheimers & Dementia. 15. DOI: 10.1016/J.Jalz.2019.06.4502 |
0.481 |
|
| 2019 |
Bateman R, Schindler SE, Bollinger JG, Ovod V, Mawuenyega KG, Li Y, Gordon BA, Holtzman DM, Morris JC, Benzinger TL, Xiong C, Fagan AM. F2-07-01: BLOOD AMYLOID-BETA PREDICTS AMYLOID PET CONVERSION Alzheimer's & Dementia. 15: P526-P526. DOI: 10.1016/J.Jalz.2019.06.4440 |
0.651 |
|
| 2019 |
Flores S, Gordon BA, Su Y, Christensen J, Dincer A, Adedokun A, Wang Q, Hornbeck RC, Morris JC, Benzinger TL. QUANTIFYING OFF-TARGET SKULL BINDING IN TAU PET STUDIES USING A CT-BASED MASK Alzheimer's & Dementia. 15: P149-P150. DOI: 10.1016/j.jalz.2019.06.4306 |
0.401 |
|
| 2019 |
Flores S, Gordon BA, Su Y, Christensen J, Dincer A, Adedokun A, Wang Q, Hornbeck RC, Morris JC, Benzinger TL. P4-268: QUANTIFYING OFF-TARGET SKULL BINDING IN TAU PET STUDIES USING A CT-BASED MASK Alzheimer's & Dementia. 15: P1384-P1385. DOI: 10.1016/J.Jalz.2019.06.3937 |
0.541 |
|
| 2019 |
Wang Q, Dincer A, McCullough AA, Hassenstab J, Gordon BA, Liu J, Morris JC, Benzinger TLS, Wang Y. P4-261: White Matter Vasogenic Edema And Its Association With Neuropsychological Measures In Alzheimer Disease Alzheimers & Dementia. 15: 149. DOI: 10.1016/J.Jalz.2019.06.3930 |
0.522 |
|
| 2019 |
Flores S, Su Y, Gordon BA, Adedokun A, Marple LM, Wang Q, Chen G, Hornbeck RC, Jack CR, Roberson ED, Soucy J, Noto RB, Brooks WS, Jiménez-Velázquez IZ, Gauthier S, et al. P3-426: REGIONAL AND VOXEL-WISE SPATIAL RELATIONSHIPS AMONG FLUORINE-18 AMYLOID PET TRACERS AND PITTSBURGH COMPOUND B Alzheimer's & Dementia. 15: P1122-P1122. DOI: 10.1016/J.Jalz.2019.06.3460 |
0.51 |
|
| 2019 |
Vlassenko AG, Gordon BA, Durbin TJ, Couture LE, Morris JC, Benzinger TL, Raichle ME, Goyal MS. P3-407: PIB BINDING TOPOGRAPHY BEST CORRELATES WITH YOUNG ADULT GLYCOLYSIS Alzheimer's & Dementia. 15: P1109-P1110. DOI: 10.1016/J.Jalz.2019.06.3441 |
0.366 |
|
| 2019 |
Dincer A, Mehrotra V, Aschenbrenner AJ, McCullough AA, Duchek JM, Balota DA, Chen G, Hornbeck RC, Morris JC, Benzinger TL, Gordon BA. P2-412: PRECLINICAL AD PATHOLOGY PARTIALLY MEDIATES THE RELATIONSHIP BETWEEN CORTICAL THICKNESS AND ATTENTIONAL CONTROL Alzheimer's & Dementia. 15: P765-P766. DOI: 10.1016/J.Jalz.2019.06.2819 |
0.699 |
|
| 2019 |
Day GS, Gordon BA, McCullough AA, Perrin RJ, Xu J, Ances BM. IC-P-166: TAU PET IMAGING IN LGI1 ENCEPHALITIS: DECIPHERING THE CONTRIBUTORS TO COGNITIVE IMPAIRMENT IN AUTOIMMUNE ENCEPHALITIS Alzheimer's & Dementia. 15: P131-P131. DOI: 10.1016/J.Jalz.2019.06.2801 |
0.374 |
|
| 2018 |
Wang G, Xiong C, McDade EM, Hassenstab J, Aschenbrenner AJ, Fagan AM, Benzinger TLS, Gordon BA, Morris JC, Li Y, Bateman RJ. Simultaneously evaluating the effect of baseline levels and longitudinal changes in disease biomarkers on cognition in dominantly inherited Alzheimer's disease. Alzheimer's & Dementia (New York, N. Y.). 4: 669-676. PMID 30569014 DOI: 10.1016/J.Trci.2018.10.009 |
0.755 |
|
| 2018 |
Bussy A, Snider BJ, Coble D, Xiong C, Fagan AM, Cruchaga C, Benzinger TLS, Gordon BA, Hassenstab J, Bateman RJ, Morris JC. Effect of apolipoprotein E4 on clinical, neuroimaging, and biomarker measures in noncarrier participants in the Dominantly Inherited Alzheimer Network. Neurobiology of Aging. 75: 42-50. PMID 30530186 DOI: 10.1016/J.Neurobiolaging.2018.10.011 |
0.75 |
|
| 2018 |
Joseph-Mathurin N, Su Y, Blazey TM, Jasielec M, Vlassenko A, Friedrichsen K, Gordon BA, Hornbeck RC, Cash L, Ances BM, Veale T, Cash DM, Brickman AM, Buckles V, Cairns NJ, et al. Utility of perfusion PET measures to assess neuronal injury in Alzheimer's disease. Alzheimer's & Dementia (Amsterdam, Netherlands). 10: 669-677. PMID 30417072 DOI: 10.1016/J.Dadm.2018.08.012 |
0.666 |
|
| 2018 |
Schultz SA, Gordon BA, Mishra S, Su Y, Perrin RJ, Cairns NJ, Morris JC, Ances BM, Benzinger TLS. Widespread distribution of tauopathy in preclinical Alzheimer's disease. Neurobiology of Aging. 72: 177-185. PMID 30292840 DOI: 10.1016/J.Neurobiolaging.2018.08.022 |
0.646 |
|
| 2018 |
McDade E, Wang G, Gordon BA, Hassenstab J, Benzinger TLS, Buckles V, Fagan AM, Holtzman DM, Cairns NJ, Goate AM, Marcus DS, Morris JC, Paumier K, Xiong C, Allegri R, et al. Longitudinal cognitive and biomarker changes in dominantly inherited Alzheimer disease. Neurology. PMID 30217935 DOI: 10.1212/Wnl.0000000000006277 |
0.745 |
|
| 2018 |
Aschenbrenner AJ, Gordon BA, Benzinger TLS, Morris JC, Hassenstab JJ. Influence of tau PET, amyloid PET, and hippocampal volume on cognition in Alzheimer disease. Neurology. PMID 30068637 DOI: 10.1212/Wnl.0000000000006075 |
0.66 |
|
| 2018 |
Su Y, Flores S, Hornbeck RC, Speidel B, Vlassenko AG, Gordon BA, Koeppe RA, Klunk WE, Xiong C, Morris JC, Benzinger TLS. Utilizing the Centiloid scale in cross-sectional and longitudinal PiB PET studies. Neuroimage. Clinical. 19: 406-416. PMID 30035025 DOI: 10.1016/J.Nicl.2018.04.022 |
0.567 |
|
| 2018 |
Hsu S, Gordon BA, Hornbeck R, Norton JB, Levitch D, Louden A, Ziegemeier E, Laforce R, Chhatwal J, Day GS, McDade E, Morris JC, Fagan AM, Benzinger TLS, Goate AM, et al. Discovery and validation of autosomal dominant Alzheimer's disease mutations. Alzheimer's Research & Therapy. 10: 67. PMID 30021643 DOI: 10.1186/S13195-018-0392-9 |
0.746 |
|
| 2018 |
Strain JF, Smith RX, Beaumont H, Roe CM, Gordon BA, Mishra S, Adeyemo B, Christensen JJ, Su Y, Morris JC, Benzinger TLS, Ances BM. Loss of white matter integrity reflects tau accumulation in Alzheimer disease defined regions. Neurology. PMID 29959265 DOI: 10.1212/Wnl.0000000000005864 |
0.676 |
|
| 2018 |
Gordon BA, McCullough A, Mishra S, Blazey TM, Su Y, Christensen J, Dincer A, Jackson K, Hornbeck RC, Morris JC, Ances BM, Benzinger TLS. Cross-sectional and longitudinal atrophy is preferentially associated with tau rather than amyloid β positron emission tomography pathology. Alzheimer's & Dementia (Amsterdam, Netherlands). 10: 245-252. PMID 29780869 DOI: 10.1016/J.Dadm.2018.02.003 |
0.673 |
|
| 2018 |
Sato C, Barthélemy NR, Mawuenyega KG, Patterson BW, Gordon BA, Jockel-Balsarotti J, Sullivan M, Crisp MJ, Kasten T, Kirmess KM, Kanaan NM, Yarasheski KE, Baker-Nigh A, Benzinger TLS, Miller TM, et al. Tau Kinetics in Neurons and the Human Central Nervous System. Neuron. 98: 861-864. PMID 29772204 DOI: 10.1016/J.Neuron.2018.04.035 |
0.579 |
|
| 2018 |
Mishra S, Blazey TM, Holtzman DM, Cruchaga C, Su Y, Morris JC, Benzinger TLS, Gordon BA. Longitudinal brain imaging in preclinical Alzheimer disease: impact of APOE ɛ4 genotype. Brain : a Journal of Neurology. PMID 29672664 DOI: 10.1093/Brain/Awy103 |
0.656 |
|
| 2018 |
Vlassenko AG, Gordon BA, Goyal MS, Su Y, Blazey TM, Durbin TJ, Couture LE, Christensen JJ, Jafri H, Morris JC, Raichle ME, Benzinger TL. Aerobic glycolysis and tau deposition in preclinical Alzheimer's disease. Neurobiology of Aging. 67: 95-98. PMID 29655050 DOI: 10.1016/J.Neurobiolaging.2018.03.014 |
0.651 |
|
| 2018 |
Sato C, Barthélemy NR, Mawuenyega KG, Patterson BW, Gordon BA, Jockel-Balsarotti J, Sullivan M, Crisp MJ, Kasten T, Kirmess KM, Kanaan NM, Yarasheski KE, Baker-Nigh A, Benzinger TLS, Miller TM, et al. Tau Kinetics in Neurons and the Human Central Nervous System. Neuron. 97: 1284-1298.e7. PMID 29566794 DOI: 10.1016/J.Neuron.2018.02.015 |
0.646 |
|
| 2018 |
Schindler SE, Gray JD, Gordon BA, Xiong C, Batrla-Utermann R, Quan M, Wahl S, Benzinger TLS, Holtzman DM, Morris JC, Fagan AM. Cerebrospinal fluid biomarkers measured by Elecsys assays compared to amyloid imaging. Alzheimer's & Dementia : the Journal of the Alzheimer's Association. PMID 29501462 DOI: 10.1016/J.Jalz.2018.01.013 |
0.649 |
|
| 2018 |
Bennett DA, Gordon BA. Alzheimer disease biomarkers and synucleinopathy. Neurology. PMID 29467302 DOI: 10.1212/Wnl.0000000000005171 |
0.523 |
|
| 2018 |
Day GS, Gordon BA, Perrin RJ, Cairns NJ, Beaumont H, Schwetye K, Ferguson C, Sinha N, Bucelli R, Musiek ES, Ghoshal N, Ponisio MR, Vincent B, Mishra S, Jackson K, et al. In vivo [18F]-AV-1451 tau-PET imaging in sporadic Creutzfeldt-Jakob disease. Neurology. PMID 29438042 DOI: 10.1212/Wnl.0000000000005064 |
0.594 |
|
| 2018 |
Gordon BA, Blazey TM, Su Y, Hari-Raj A, Dincer A, Flores S, Christensen J, McDade E, Wang G, Xiong C, Cairns NJ, Hassenstab J, Marcus DS, Fagan AM, Jack CR, et al. Spatial patterns of neuroimaging biomarker change in individuals from families with autosomal dominant Alzheimer's disease: a longitudinal study. The Lancet. Neurology. PMID 29397305 DOI: 10.1016/S1474-4422(18)30028-0 |
0.738 |
|
| 2018 |
Koenig LN, Keefe S, Marple LM, Blazey T, Gordon BA, Hassenstab J, Morris JC, Miller-Thomas M, Shimony JS, Benzinger TLS. P1-390: Volumetric-Based Diagnosis Of Alzheimer'S Disease Using A Super-Normal Cohort Of Aging Alzheimers & Dementia. 14. DOI: 10.1016/J.Jalz.2018.06.398 |
0.639 |
|
| 2018 |
Gray JD, Sutphen CL, Henson RL, Orusakwe A, Traynham C, Vandijck M, Gailey R, Lawson J, Gordon BA, Benzinger TLS, Morris JC, Fagan AM. P1-290: Concordance Between In Vivo Amyloid Imaging And Csf Ab1-42 And Total Tau Measured By The Automated Lumipulse® G Assay Platform Alzheimers & Dementia. 14. DOI: 10.1016/J.Jalz.2018.06.296 |
0.584 |
|
| 2018 |
McDade E, Li Y, Wang G, Gordon BA, Hassenstab J, Benzinger TLS, Fagan AM, Goate AM, Morris JC, Cash DM, Fox NC, Xiong C, Holtzman DM, Bateman RJ. O2-04-03: What Goes Up Must Come Down: Longitudinal Decline In Cerebrospinal Fluid Tau Peptides Is Associated With Progressive Cortical Atrophy Alzheimers & Dementia. 14. DOI: 10.1016/J.Jalz.2018.06.2659 |
0.422 |
|
| 2018 |
Gordon BA, Blazey T, Christensen J, Flores S, Dincer A, Keefe S, McDade E, Wang G, Raichle ME, Koeppe B, Jack CR, Morris JC, Bateman RJ, Benzinger TLS. The Relationship Between Tau Pet And Other Ad Biomarkers In Autosomal Dominant Alzheimer Disease Alzheimers & Dementia. 14. DOI: 10.1016/J.Jalz.2018.06.2271 |
0.603 |
|
| 2018 |
Strain JF, Tanenbaum A, Smith RX, Fagan AM, Gordon BA, Hassenstab J, Xiong C, McDade E, Chhatwal JP, Morris JC, Benzinger TLS, Bateman RJ, Ances BM, Dian. Ic-P-043: Functional Architectural Differences Between Autosomal Dominant Alzheimer'S Disease And Late Onset Alzheimer'S Disease Alzheimers & Dementia. 14. DOI: 10.1016/J.Jalz.2018.06.2107 |
0.545 |
|
| 2018 |
Smith RX, Tanenbaum A, Strain JF, Gordon BA, Fagan AM, Hassenstab J, McDade E, Xiong C, Chhatwal JP, Morris JC, Benzinger TLS, Bateman RJ, Ances BM. P4-108: Resting-State Functional Connectivity Is Associated With Pathological Biomarkers In Autosomal Dominant Alzheimer'S Disease Alzheimers & Dementia. 14. DOI: 10.1016/J.Jalz.2018.06.2106 |
0.542 |
|
| 2018 |
Flores S, Su Y, Wang G, Hornbeck RC, Speidel B, Vlassenko AG, Gordon BA, Mintun MA, Koeppe RA, Klunk WE, Xiong C, Morris JC, Bateman RJ, Benzinger TLS. Ic-P-009: Comparing The Centiloid Scale For Pittsburgh Compound B And Florbetapir In Longitudinal Pet Studies Of Sporadic Ad Alzheimers & Dementia. 14: 19. DOI: 10.1016/J.Jalz.2018.06.2073 |
0.443 |
|
| 2018 |
Schultz SA, Apel A, Preische O, Kuhle J, Gordon BA, Wang G, McDade E, Bateman RJ, Morris JC, Benzinger TLS, Jucker M. Ic-04-02: Serum Neurofilament Light Chain Levels Are Associated With Cortical Thickness, Beta-Amyloid Burden, And Cerebral Glucose Metabolism In Autosomal Dominant Alzheimer Disease Alzheimers & Dementia. 14. DOI: 10.1016/J.Jalz.2018.06.2050 |
0.592 |
|
| 2018 |
Preische O, Schultz SA, Apel A, Kuhle J, Gordon BA, Wang G, McDade E, Bateman RJ, Morris JC, Benzinger TLS, Jucker M. P3-251: Serum Neurofilament Light Chain Levels Are Associated With Csf Neurofilament Light Chain, Cognitive Status, And Disease Progression In Autosomal Dominant Ad Alzheimers & Dementia. 14. DOI: 10.1016/J.Jalz.2018.06.1611 |
0.604 |
|
| 2018 |
Strain JF, Smith RX, Wang Q, Fagan AM, Gordon BA, Hassenstab J, Xiong C, McDade E, Morris JC, Benzinger TLS, Bateman RJ, Ances BM, Dian. P2-464: Biological Correlates Of White Matter Changes In Autosomal Dominant Alzheimer'S Disease Alzheimers & Dementia. 14. DOI: 10.1016/J.Jalz.2018.06.1157 |
0.52 |
|
| 2017 |
Roe CM, Babulal GM, Mishra S, Gordon BA, Stout SH, Ott BR, Carr DB, Ances BM, Morris JC, Benzinger TLS. Tau and Amyloid Positron Emission Tomography Imaging Predict Driving Performance Among Older Adults with and without Preclinical Alzheimer's Disease. Journal of Alzheimer's Disease : Jad. PMID 29171997 DOI: 10.3233/Jad-170521 |
0.677 |
|
| 2017 |
Lewczuk P, Riederer P, O'Bryant SE, Verbeek MM, Dubois B, Visser PJ, Jellinger KA, Engelborghs S, Ramirez A, Parnetti L, Jack CR, Teunissen CE, Hampel H, Lleó A, Jessen F, ... ... Gordon BA, et al. Cerebrospinal fluid and blood biomarkers for neurodegenerative dementias: An update of the Consensus of the Task Force on Biological Markers in Psychiatry of the World Federation of Societies of Biological Psychiatry. The World Journal of Biological Psychiatry : the Official Journal of the World Federation of Societies of Biological Psychiatry. 1-85. PMID 29076399 DOI: 10.1080/15622975.2017.1375556 |
0.331 |
|
| 2017 |
Mishra S, Gordon BA, Su Y, Christensen J, Friedrichsen K, Jackson K, Hornbeck R, Balota DA, Cairns NJ, Morris JC, Ances BM, Benzinger TLS. AV-1451 PET imaging of tau pathology in preclinical Alzheimer disease: Defining a summary measure. Neuroimage. PMID 28756238 DOI: 10.1016/J.Neuroimage.2017.07.050 |
0.762 |
|
| 2017 |
Day GS, Gordon BA, Jackson K, Christensen JJ, Rosana Ponisio M, Su Y, Ances BM, Benzinger TL, Morris JC. Tau-PET Binding Distinguishes Patients With Early-stage Posterior Cortical Atrophy From Amnestic Alzheimer Disease Dementia. Alzheimer Disease and Associated Disorders. PMID 28394771 DOI: 10.1097/Wad.0000000000000196 |
0.676 |
|
| 2017 |
Aschenbrenner AJ, Hassenstab J, Gordon BA, Benzinger TL, Morris JC. NEUROIMAGING BIOMARKERS OF THE A/T/N CLASSIFICATION SYSTEM PREDICT CROSS-SECTIONAL AND LONGITUDINAL CHANGE IN PRECLINICAL AND EARLY ALZHEIMER DISEASE Alzheimer's & Dementia. 13: P911. DOI: 10.1016/J.Jalz.2017.07.332 |
0.477 |
|
| 2017 |
Ly CV, Koenig L, Beaumont H, Gordon BA, Christensen J, Su Y, Nelson B, Jockel-Balsarotti J, Drain C, Jerome G, Fagan AM, Harms M, Benzinger TL, Miller TM, Ances BM. IN VIVO TAU IMAGING BY POSITRON EMISSION TOMOGRAPHY IN PATIENTS WITH C9ORF72 HEXANUCLEOTIDE REPEAT EXPANSIONS Alzheimer's & Dementia. 13: P904-P905. DOI: 10.1016/J.Jalz.2017.07.318 |
0.302 |
|
| 2017 |
McDade E, Wang G, Benzinger TL, Buckles VD, Fagan AM, Gordon BA, Hassenstab J, Holtzman DM, Cairns NJ, Goate AM, Marcus DS, Morris JC, Paumier KL, Xiong C, Ricardo A, et al. LONGITUDINAL BIOMARKER CHANGES IN AUTOSOMAL DOMINANT ALZHEIMER'S DISEASE FROM THE DIAN STUDY Alzheimer's & Dementia. 13: P879-P880. DOI: 10.1016/J.Jalz.2017.07.265 |
0.669 |
|
| 2017 |
Fagan AM, Schindler SE, Gray JD, Gordon BA, Xiong C, Batrla-Utermann R, Quan M, Wahl S, Buckles VD, Benzinger TL, Morris JC. CONCORDANCE BETWEEN CSF AD BIOMARKERS MEASURED BY THE AUTOMATED ELECSYS ASSAY AND IN VIVO AMYLOID IMAGING Alzheimer's & Dementia. 13: P561. DOI: 10.1016/J.Jalz.2017.07.169 |
0.628 |
|
| 2017 |
Morris JC, Benzinger TL, Buckles VD, Fagan AM, Gordon BA, Grant EA, McCue L, Moulder KL, Schindler SE, Xiong C. RACIAL DIFFERENCES AND SIMILARITIES IN MOLECULAR BIOMARKERS FOR AD Alzheimer's & Dementia. 13: P560-P561. DOI: 10.1016/J.Jalz.2017.07.168 |
0.614 |
|
| 2017 |
Gordon BA, Blazey T, Su Y, Hari-Raj A, Dincer A, Flores S, Christensen J, McDade E, Wang G, Xiong C, Cairns NJ, Hassenstab J, Fagan AM, Marcus DS, Jack CR, et al. EXAMINING LONGITUDINAL NEUROIMAGING PATTERNS IN AUTOSOMAL DOMINANT ALZHEIMER DISEASE: FINDINGS FROM THE DOMINANTLY INHERITED ALZHEIMER NETWORK Alzheimer's & Dementia. 13: P186. DOI: 10.1016/j.jalz.2017.07.041 |
0.374 |
|
| 2017 |
Mishra S, Blazey T, Su Y, Christensen J, Jackson K, Hornbeck RC, Cruchaga C, Morris JC, Ances BM, Benzinger TL, Gordon BA. [P2-345]: APOE4 EFFECT ON LONGITUDINAL VOLUMETRICS AND PIB ACCUMULATION IN PRECLINICAL ALZHEIMER DISEASE Alzheimer's & Dementia. 13: P754-P754. DOI: 10.1016/j.jalz.2017.06.999 |
0.57 |
|
| 2017 |
Mishra S, Gordon BA, Blazey T, Su Y, Christensen J, Jackson K, Hornbeck RC, Morris JC, Ances BM, Benzinger TL. [P1-422]: RELATIONSHIP BETWEEN TAU POSITRON EMISSION TOMOGRAPHY WITH [18F]-AV-1451 AND LONGITUDINAL CORTICAL ATROPHY IN ALZHEIMER DISEASE Alzheimer's & Dementia. 13: P440-P440. DOI: 10.1016/j.jalz.2017.06.438 |
0.525 |
|
| 2017 |
Vlassenko AG, Gordon BA, Goyal MS, Su Y, Durbin TJ, Couture LE, Holtzman DM, Morris JC, Fagan AM, Benzinger TL, Bateman RJ, Raichle ME. [P1-402]: BRAIN AEROBIC GLYCOLYSIS AND AD PATHOLOGY BIOMARKERS IN AUTOSOMAL DOMINANT AD Alzheimer's & Dementia. 13: P427-P428. DOI: 10.1016/j.jalz.2017.06.418 |
0.347 |
|
| 2017 |
Schultz SA, Gordon BA, Mishra S, Morris JC, Duchek JM, Balota DA, Benzinger TL, Ances B. [P1-351]: THE ASSOCIATION BETWEEN PERSONALITY AND TAU PET DEPOSITION IN COGNITIVELY NORMAL OLDER ADULTS: FINDINGS FROM THE KNIGHT ALZHEIMER DISEASE RESEARCH CENTER Alzheimer's & Dementia. 13: P391-P392. DOI: 10.1016/j.jalz.2017.06.367 |
0.348 |
|
| 2017 |
Mishra S, Gordon BA, Blazey T, Su Y, Christensen J, Jackson K, Hornbeck RC, Morris JC, Ances BM, Benzinger TL. [IC-02-02]: RELATIONSHIP BETWEEN TAU POSITRON EMISSION TOMOGRAPHY WITH [18F]-AV-1451 AND LONGITUDINAL CORTICAL ATROPHY IN ALZHEIMER DISEASE Alzheimer's & Dementia. 13: P4-P5. DOI: 10.1016/j.jalz.2017.06.2627 |
0.51 |
|
| 2017 |
Mishra S, Gordon BA, Blazey T, Su Y, Christensen J, Jackson K, Hornbeck RC, Morris JC, Ances BM, Benzinger TL. RELATIONSHIP BETWEEN TAU POSITRON EMISSION TOMOGRAPHY WITH [18F]-AV-1451 AND LONGITUDINAL CORTICAL ATROPHY IN ALZHEIMER DISEASE Alzheimer's & Dementia. 13: P233-P234. DOI: 10.1016/J.Jalz.2017.06.2627 |
0.63 |
|
| 2017 |
Vlassenko AG, Gordon BA, Goyal MS, Su Y, Jackson K, Durbin TJ, Couture LE, Morris JC, Benzinger TL, Raichle ME. BRAIN AEROBIC GLYCOLYSIS AND TAU DEPOSITION WITH [18F]-AV-1451 PET Alzheimer's & Dementia. 13: P922. DOI: 10.1016/J.Jalz.2017.06.2581 |
0.433 |
|
| 2017 |
Schultz SA, Gordon BA, Mishra S, Morris JC, Duchek JM, Balota DA, Benzinger TL, Ances B. THE ASSOCIATION BETWEEN PERSONALITY AND TAU PET DEPOSITION IN COGNITIVELY NORMAL OLDER ADULTS: FINDINGS FROM THE KNIGHT ALZHEIMER DISEASE RESEARCH CENTER Alzheimer's & Dementia. 13: P145-P146. DOI: 10.1016/J.Jalz.2017.06.2572 |
0.68 |
|
| 2017 |
Day GS, Gordon BA, Perrin RJ, Cairns NJ, Schwetye KE, Ferguson CJ, Sinha N, Ponisio MR, Vincent BD, Beaumont H, Bucelli RC, Ghoshal N, Musiek ES, Morris JC, Benzinger TL, et al. FLORTAUCIPIR TAU-PET SPECIFICITY IS MAINTAINED IN PATIENTS WITH PATHOLOGICALLY CONFIRMED CREUTZFELDT-JAKOB DISEASE Alzheimer's & Dementia. 13: P900-P901. DOI: 10.1016/J.Jalz.2017.06.2555 |
0.515 |
|
| 2017 |
Hari-Raj A, Dincer A, Gordon BA, Su Y, Ances BM, Morris JC, Bateman RJ, Benzinger TL. [IC-P-138]: CORTICAL THINNING PATTERN IN AUTOSOMAL DOMINANT AD PREDICTS AMYLOID POSITIVITY IN SPORADIC AD Alzheimer's & Dementia. 13: P105-P105. DOI: 10.1016/j.jalz.2017.06.2412 |
0.512 |
|
| 2017 |
Hari-Raj A, Dincer A, Gordon BA, Su Y, Ances BM, Morris JC, Bateman RJ, Benzinger TL. CORTICAL THINNING PATTERN IN AUTOSOMAL DOMINANT AD PREDICTS AMYLOID POSITIVITY IN SPORADIC AD Alzheimer's & Dementia. 13: P184-P185. DOI: 10.1016/J.Jalz.2017.06.2412 |
0.628 |
|
| 2017 |
Vlassenko AG, Gordon BA, Goyal MS, Su Y, Durbin TJ, Couture LE, Holtzman DM, Morris JC, Fagan AM, Benzinger TL, Bateman RJ, Raichle ME. [IC-P-064]: BRAIN AEROBIC GLYCOLYSIS AND AD PATHOLOGY BIOMARKERS IN AUTOSOMAL DOMINANT AD Alzheimer's & Dementia. 13: P53-P53. DOI: 10.1016/J.Jalz.2017.06.2337 |
0.641 |
|
| 2017 |
Mishra S, Blazey T, Su Y, Christensen J, Jackson K, Hornbeck RC, Cruchaga C, Morris JC, Ances BM, Benzinger TL, Gordon BA. [IC-P-061]: APOE4 EFFECT ON LONGITUDINAL VOLUMETRICS AND PIB ACCUMULATION IN PRECLINICAL ALZHEIMER DISEASE Alzheimer's & Dementia. 13: P50-P50. DOI: 10.1016/J.Jalz.2017.06.2334 |
0.624 |
|
| 2017 |
Joseph-Mathurin N, Kantarci K, Jack CR, Ringman JM, Salloway S, McDade E, Clifford D, Blazey T, Friedrichsen KA, Su Y, Gordon BA, Hornbeck RC, Mills S, Ances BM, Raichle ME, et al. Clinical Risk Related To Cerebral Microhemorrhages In Autosomal Dominant Alzheimer’S Disease: Longitudinal Results From The Dian Study Alzheimers & Dementia. 13: 47. DOI: 10.1016/J.Jalz.2017.06.2330 |
0.441 |
|
| 2017 |
Gordon BA, Blazey T, Su Y, Hari-Raj A, Dincer A, Flores S, Christensen J, McDade E, Wang G, Xiong C, Cairns NJ, Hassenstab J, Fagan AM, Marcus DS, Jack CR, et al. [IC-P-054]: EXAMINING LONGITUDINAL NEUROIMAGING PATTERNS IN AUTOSOMAL DOMINANT ALZHEIMER DISEASE: RESULTS FROM THE DOMINANTLY INHERITED ALZHEIMER NETWORK Alzheimer's & Dementia. 13: P44-P45. DOI: 10.1016/J.Jalz.2017.06.2327 |
0.529 |
|
| 2017 |
Strain JF, Smith R, Beaumont H, Gordon BA, Mishra S, Christensen J, Morris JC, Benzinger TL, Ances BM. [P4-244]: WHITE MATTER INTEGRITY REFLECTS TAU ACCUMULATION IN AD-DEFINED REGIONS Alzheimer's & Dementia. 13: P1370-P1371. DOI: 10.1016/J.Jalz.2017.06.2112 |
0.508 |
|
| 2017 |
Schultz SA, Gordon BA, Mishra S, Su Y, Morris JC, Benzinger TL, Ances B. TAU DISTRIBUTION IN PRECLINICAL ALZHEIMER’s DISEASE: FINDINGS FROM THE KNIGHT ALZHEIMER’S DISEASE RESEARCH CENTER Alzheimer's & Dementia. 13: P144-P145. DOI: 10.1016/J.Jalz.2017.06.1029 |
0.61 |
|
| 2017 |
Schultz SA, Gordon BA, Mishra S, Su Y, Morris JC, Ances B, Benzinger TL. [P2-374]: TAU DISTRIBUTION IN PRECLINICAL ALZHEIMER'S DISEASE: FINDINGS FROM THE KNIGHT ALZHEIMER'S DISEASE RESEARCH CENTER Alzheimer's & Dementia. 13: P769-P770. DOI: 10.1016/j.jalz.2017.06.1029 |
0.383 |
|
| 2017 |
Joseph-Mathurin N, Su Y, Blazey T, Jasielec MS, Vlassenko AG, Friedrichsen KA, Gordon BA, Hornbeck RC, Cash L, Ances BM, Raichle ME, Brickman AM, Buckles V, Cairns NJ, Cruchaga C, et al. Utility Of Perfusion Pet Models As Measures Of Neurodegeneration In An Autosomal Dominant Alzheimer’S Disease Population: Report From The Dian Study Alzheimers & Dementia. 13. DOI: 10.1016/J.Jalz.2017.06.1027 |
0.447 |
|
| 2016 |
Natelson Love M, Clark DG, Cochran JN, Den Beste KA, Geldmacher DS, Benzinger TL, Gordon BA, Morris JC, Bateman RJ, Roberson ED. Clinical, imaging, pathological, and biochemical characterization of a novel presenilin 1 mutation (N135Y) causing Alzheimer's disease. Neurobiology of Aging. PMID 27793474 DOI: 10.1016/J.Neurobiolaging.2016.09.020 |
0.723 |
|
| 2016 |
Gordon BA, Blazey T, Su Y, Fagan AM, Holtzman DM, Morris JC, Benzinger TL. Longitudinal β-Amyloid Deposition and Hippocampal Volume in Preclinical Alzheimer Disease and Suspected Non-Alzheimer Disease Pathophysiology. Jama Neurology. PMID 27548756 DOI: 10.1001/Jamaneurol.2016.2642 |
0.675 |
|
| 2016 |
Fletcher MA, Low KA, Boyd R, Zimmerman B, Gordon BA, Tan CH, Schneider-Garces N, Sutton BP, Gratton G, Fabiani M. Comparing Aging and Fitness Effects on Brain Anatomy. Frontiers in Human Neuroscience. 10: 286. PMID 27445740 DOI: 10.3389/Fnhum.2016.00286 |
0.778 |
|
| 2016 |
Vlassenko AG, McCue L, Jasielec MS, Su Y, Gordon BA, Xiong C, Holtzman DM, Benzinger TL, Morris JC, Fagan AM. Imaging and cerebrospinal fluid biomarkers in early preclinical Alzheimer disease. Annals of Neurology. PMID 27398953 DOI: 10.1002/Ana.24719 |
0.681 |
|
| 2016 |
Vos SJ, Gordon BA, Su Y, Visser PJ, Holtzman DM, Morris JC, Fagan AM, Benzinger TL. NIA-AA staging of preclinical Alzheimer disease: discordance and concordance of CSF and imaging biomarkers. Neurobiology of Aging. 44: 1-8. PMID 27318129 DOI: 10.1016/J.Neurobiolaging.2016.03.025 |
0.663 |
|
| 2016 |
Gordon BA, Friedrichsen K, Brier M, Blazey T, Su Y, Christensen J, Aldea P, McConathy J, Holtzman DM, Cairns NJ, Morris JC, Fagan AM, Ances BM, Benzinger TL. The relationship between cerebrospinal fluid markers of Alzheimer pathology and positron emission tomography tau imaging. Brain : a Journal of Neurology. PMID 27286736 DOI: 10.1093/Brain/Aww139 |
0.68 |
|
| 2016 |
Brier MR, Gordon B, Friedrichsen K, McCarthy J, Stern A, Christensen J, Owen C, Aldea P, Su Y, Hassenstab J, Cairns NJ, Holtzman DM, Fagan AM, Morris JC, Benzinger TL, et al. Tau and Aβ imaging, CSF measures, and cognition in Alzheimer's disease. Science Translational Medicine. 8: 338ra66. PMID 27169802 DOI: 10.1126/Scitranslmed.Aaf2362 |
0.712 |
|
| 2016 |
Vos SJB, Gordon BA, Su Y, Visser PJ, Holtzman DM, Morris JC, Fagan AM, Benzinger TLS. NIA-AA staging of preclinical Alzheimer disease: Discordance and concordance of CSF and imaging biomarkers Neurobiology of Aging. 44: 1-8. DOI: 10.1016/j.neurobiolaging.2016.03.025 |
0.38 |
|
| 2016 |
Day GS, Gordon BA, Benzinger TL, Morris JC. P4-337: IN VIVO
Quantification of Regional TAU Deposition in Patients with Progressive Posterior Cortical Dysfunction Alzheimer's & Dementia. 12: P1163-P1164. DOI: 10.1016/J.Jalz.2016.07.081 |
0.438 |
|
| 2016 |
Mishra S, Gordon BA, Friedrichsen KA, Su Y, Christensen J, Aldea P, Cairns NJ, Morris JC, Ances B, Benzinger TL. P1-116: Classifying TAU Pet Positivity with [18F]-AV-1451 in Preclinical Alzheimer's Disease Alzheimer's & Dementia. 12: P446-P447. DOI: 10.1016/j.jalz.2016.06.864 |
0.33 |
|
| 2016 |
Benzinger TLS, Gordon BA, Friedrichsen KA, Su Y, Christensen J, Hornbeck RC, Mishra S, Aldea P, Cash L, Ances B, McConathy J, Koeppe RA, McDade E, Cairns NJ, Morris JC, et al. Tau Pet Imaging With Av-1451 In Autosomal Dominant Alzheimer'S Disease: Update From The Dominantly Inherited Alzheimer Network (Dian) Alzheimers & Dementia. 12: 378. DOI: 10.1016/J.Jalz.2016.06.709 |
0.737 |
|
| 2016 |
Joseph-Mathurin N, Vlassenko AG, Fagan AM, Su Y, Friedrichsen KA, Owen CJ, Gordon BA, Hornbeck RC, Koeppe RA, Xiong C, Morris JC, Bateman R, Benzinger TL. Neuronal Injury And Degeneration Evaluated With Imaging And Csf Biomarkers In Autosomal Dominant Alzheimer'S Disease: Results From The Dian Study Alzheimers & Dementia. 12: 246. DOI: 10.1016/J.Jalz.2016.06.440 |
0.619 |
|
| 2016 |
Gordon BA, Blazey T, Morris JC, Holtzman DM, Fagan AM, Benzinger TL. O1-07-04: Longitudinal Amyloid Deposition and Hippocampal Volume in Suspected Non-Alzheimer Pathophysiology and Preclinical Alzheimer's Disease Alzheimer's & Dementia. 12: P191-P191. DOI: 10.1016/J.Jalz.2016.06.332 |
0.565 |
|
| 2016 |
Friedrichsen KA, Ghoshal N, Joseph-Mathurin N, Mishra S, Su Y, Christensen J, Aldea P, McConathy J, Gordon BA, Ances B, Cairns NJ, Morris JC, Benzinger TL. IC-P-206: Similarities and Differences in Patterns of [F18]-Av-1451 And [F18]-FDG in Frontotemporal Dementia Alzheimer's & Dementia. 12: P147-P147. DOI: 10.1016/J.Jalz.2016.06.238 |
0.389 |
|
| 2016 |
Friedrichsen KA, Mishra S, Gordon BA, Ghoshal N, Su Y, Joseph-Mathurin N, Christensen J, Aldea P, McConathy J, Ances B, Cairns NJ, Morris JC, Benzinger TL. IC-P-204: Principal Component Analysis of [18F]-Av-1451 TAU PET in Alzheimer’s Disease and Frontotemporal Dementia Alzheimer's & Dementia. 12: P145-P146. DOI: 10.1016/J.Jalz.2016.06.236 |
0.489 |
|
| 2016 |
Ances B, Brier MR, Gordon BA, Friedrichsen KA, McCarthy JE, Stern A, Christensen J, Owen CJ, Aldea P, Su Y, Hassenstab J, Cairns NJ, Holtzman DM, Fagan AM, Morris JC, et al. IC-P-179: TAU Imaging Relationships With Amyloid B Imaging, CSF TAU/AB42
, and Cognition in Alzheimer’s Disease Alzheimer's & Dementia. 12: P130-P131. DOI: 10.1016/J.Jalz.2016.06.210 |
0.523 |
|
| 2016 |
Schwarz AJ, Gordon BA, Tanenbaum A, Morris JC, Benzinger TL, Ances B. P3-283: Functional Connectivity with Anterior Temporal Lobe Regions Ordered According to the Braak Progression Scheme Reveals Sequential Coupling to Default Mode and Then Sensory Networks Alzheimer's & Dementia. 12: P946-P946. DOI: 10.1016/J.Jalz.2016.06.1946 |
0.355 |
|
| 2016 |
Gordon BA, Su Y, Holtzman DM, Fagan AM, Morris JC, Benzinger TL. P3-233: Critical Analysis of Biomarker Cutoffs in Alzheimer's Disease Alzheimer's & Dementia. 12: P915-P915. DOI: 10.1016/j.jalz.2016.06.1895 |
0.358 |
|
| 2016 |
Gordon BA, Xiong C, Holtzman DM, Fagan AM, Morris JC, Benzinger TL. IC-P-139: Critical Analysis of Biomarker Cutoffs in Alzheimer Disease Alzheimer's & Dementia. 12: P103-P104. DOI: 10.1016/J.Jalz.2016.06.169 |
0.503 |
|
| 2016 |
Joseph-Mathurin N, Vlassenko AG, Fagan AM, Su Y, Friedrichsen KA, Owen CJ, Gordon BA, Hornbeck RC, Koeppe RA, Xiong C, Morris JC, Bateman R, Benzinger TL. Neuronal Injury And Degeneration Evaluated With Imaging And Csf Biomarkers In Autosomal Dominant Ad: Results From The Dian Study Alzheimers & Dementia. 12. DOI: 10.1016/J.Jalz.2016.06.147 |
0.591 |
|
| 2016 |
Gordon BA, Friedrichsen KA, Brier MR, Blazey T, Su Y, Christensen J, McConathy J, Aldea P, Holtzman DM, Cairns NJ, Morris JC, Fagan AM, Ances B, Benzinger TL. P1-263: Relating PET and CSF Measure of TAU Pathology Alzheimer's & Dementia. 12: P513-P514. DOI: 10.1016/J.Jalz.2016.06.1012 |
0.485 |
|
| 2016 |
Mishra S, Gordon BA, Friedrichsen KA, Su Y, Christensen J, Aldea P, Cairns NJ, Morris JC, Ances B, Benzinger TL. IC-01-03: Classifying TAU Pet Positivity With [18F]-AV-1451 in Preclinical Alzheimer's Disease Alzheimer's & Dementia. 12: P2-P3. DOI: 10.1016/J.Jalz.2016.06.063 |
0.512 |
|
| 2015 |
Wang F, Gordon BA, Ryman DC, Ma S, Xiong C, Hassenstab J, Goate A, Fagan AM, Cairns NJ, Marcus DS, McDade E, Ringman JM, Graff-Radford NR, Ghetti B, Farlow MR, et al. Cerebral amyloidosis associated with cognitive decline in autosomal dominant Alzheimer disease. Neurology. PMID 26245925 DOI: 10.1212/Wnl.0000000000001903 |
0.706 |
|
| 2015 |
Aschenbrenner AJ, Balota DA, Gordon BA, Ratcliff R, Morris JC. A Diffusion Model Analysis of Episodic Recognition in Preclinical Individuals With a Family History for Alzheimer's Disease: The Adult Children Study. Neuropsychology. PMID 26192539 DOI: 10.1037/Neu0000222 |
0.652 |
|
| 2015 |
Gordon BA, Najmi S, Hsu P, Roe CM, Morris JC, Benzinger TL. The effects of white matter hyperintensities and amyloid deposition on Alzheimer dementia. Neuroimage. Clinical. 8: 246-52. PMID 26106548 DOI: 10.1016/J.Nicl.2015.04.017 |
0.668 |
|
| 2015 |
Gordon BA, Zacks JM, Blazey T, Benzinger TL, Morris JC, Fagan AM, Holtzman DM, Balota DA. Task-evoked fMRI changes in attention networks are associated with preclinical Alzheimer's disease biomarkers. Neurobiology of Aging. 36: 1771-9. PMID 25708908 DOI: 10.1016/J.Neurobiolaging.2015.01.019 |
0.8 |
|
| 2015 |
Aschenbrenner AJ, Balota DA, Gordon BA, Ratcliff R, Morris JC. A Diffusion Model Analysis of Episodic Recognition in Preclinical Individuals With a Family History for Alzheimer's Disease: The Adult Children Study Neuropsychology. DOI: 10.1037/neu0000222 |
0.585 |
|
| 2015 |
Gordon BA, Najmi S, Hsu P, Roe CM, Morris JC, Benzinger TLS. The effects of white matter hyperintensities and amyloid deposition on Alzheimer dementia Neuroimage: Clinical. 8: 246-252. DOI: 10.1016/j.nicl.2015.04.017 |
0.47 |
|
| 2015 |
Gordon BA, Vos S, Holtzman DM, Morris JC, Fagan AM, Benzinger TL. O1-01-01: Comparison of nia-aa preclinical Alzheimer's disease staging with CSF and neuroimaging biomarkers Alzheimer's & Dementia. 11: P122-P123. DOI: 10.1016/j.jalz.2015.07.027 |
0.314 |
|
| 2015 |
Friedrichsen KA, Benzinger TLS, Joseph-Mathurin N, Fagan AM, Cairns NJ, Stevenson TA, Su Y, Christensen J, McConathy J, Gordon B, McFarlane S, Ances B, Morris JC. Patterns of tau binding in T807-PET imaging Alzheimers & Dementia. 11: 110. DOI: 10.1016/J.Jalz.2015.06.187 |
0.544 |
|
| 2015 |
Owen CJ, Gordon B, Brier MR, Wang L, Wang Q, Joseph-Mathurin N, Su Y, Vlassenko A, Blazey T, Speidel B, LaMontagne P, Marcus DS, Friedrichsen KA, Hornbeck RC, Jackson K, et al. IC-P-100: The ILP: A new tool for evaluating preclinical Alzheimer's disease using volumetric MRI in a single participant Alzheimer's & Dementia. 11: P68-P68. DOI: 10.1016/J.Jalz.2015.06.121 |
0.496 |
|
| 2015 |
Joseph-Mathurin N, Tang M, Friedrichsen KA, Owen CJ, Su Y, Hornbeck RC, Stevenson TA, Cash L, Raichle ME, Gordon B, Preboske GM, Koeppe RA, Jack CR, Goate A, Cruchaga C, et al. Amyloid load increase and cerebral microbleed prevalence differ as a function of the position of the mutation within the PSEN1 coding sequence Alzheimers & Dementia. 11: 172. DOI: 10.1016/J.Jalz.2015.06.072 |
0.621 |
|
| 2015 |
Gordon BA, Hassenstab J, Fagan AM, Morris JC, Benzinger TL. IC-P-021: Lower body mass index is associated with greater Alzheimer pathology in asymptomatic individuals Alzheimer's & Dementia. 11: P25-P25. DOI: 10.1016/J.Jalz.2015.06.041 |
0.51 |
|
| 2015 |
Gordon BA, Vos S, Morris JC, Holtzman DM, Fagan AM, Benzinger TL. IC-P-020: Comparison of nia-aa preclinical Alzheimer's disease staging with CSF and neuroimaging biomarkers Alzheimer's & Dementia. 11: P24-P25. DOI: 10.1016/J.Jalz.2015.06.040 |
0.515 |
|
| 2014 |
Gordon BA, Tse CY, Gratton G, Fabiani M. Spread of activation and deactivation in the brain: does age matter? Frontiers in Aging Neuroscience. 6: 288. PMID 25360115 DOI: 10.3389/Fnagi.2014.00288 |
0.763 |
|
| 2014 |
Gordon BA, Blazey T, Benzinger TL. Regional variability in Alzheimer's disease biomarkers. Future Neurology. 9: 131-134. PMID 25309132 DOI: 10.2217/Fnl.14.9 |
0.628 |
|
| 2014 |
Kirchhoff BA, Gordon BA, Head D. Prefrontal gray matter volume mediates age effects on memory strategies. Neuroimage. 90: 326-34. PMID 24389014 DOI: 10.1016/J.Neuroimage.2013.12.052 |
0.625 |
|
| 2014 |
Fabiani M, Gordon BA, Maclin EL, Pearson MA, Brumback-Peltz CR, Low KA, McAuley E, Sutton BP, Kramer AF, Gratton G. Neurovascular coupling in normal aging: a combined optical, ERP and fMRI study. Neuroimage. 85: 592-607. PMID 23664952 DOI: 10.1016/J.Neuroimage.2013.04.113 |
0.745 |
|
| 2014 |
Gordon BA, Benzinger TL, Morris JC, Balota DA, Zacks J. IC-P-148: ALTERED TASK-EVOKED FMRI ACTIVITY IN PRECLINICAL ALZHEIMER'S DISEASE Alzheimer's & Dementia. 10: P85-P85. DOI: 10.1016/J.Jalz.2014.05.154 |
0.758 |
|
| 2014 |
Gordon BA, Benzinger T, Morris JC, Balota D, Zacks J. O2-10-05: ALTERED TASK-EVOKED FMRI ACTIVITY IN PRECLINICAL ALZHEIMER'S DISEASE Alzheimer's & Dementia. 10: P187-P188. DOI: 10.1016/j.jalz.2014.04.214 |
0.643 |
|
| 2013 |
Gordon BA, Blazey T, Benzinger TL, Head D. Effects of aging and Alzheimer's disease along the longitudinal axis of the hippocampus. Journal of Alzheimer's Disease : Jad. 37: 41-50. PMID 23780659 DOI: 10.3233/Jad-130011 |
0.767 |
|
| 2013 |
Scullin MK, Gordon BA, Shelton JT, Lee JH, Head D, McDaniel MA. Evidence for a detrimental relationship between hypertension history, prospective memory, and prefrontal cortex white matter in cognitively normal older adults. Cognitive, Affective & Behavioral Neuroscience. 13: 405-16. PMID 23389652 DOI: 10.3758/S13415-013-0152-Z |
0.632 |
|
| 2013 |
Gordon B, Blazey T, Allison S, Morris J, Benzinger T, Head D. IC-P-104: Characterization of cortical microstructural changes in Alzheimer's disease Alzheimer's & Dementia. 9: P60-P60. DOI: 10.1016/J.Jalz.2013.05.101 |
0.753 |
|
| 2012 |
신은삼, Peltz CB, Gordon BA, Mcauley E, Gratton G, Fabiani M. 노화와 노인의 신체 건강이 작업 기억에 주는 효과 Korean Journal of Cognitive and Biological Psychology. 24: 107-126. DOI: 10.22172/Cogbio.2012.24.2.002 |
0.75 |
|
| 2011 |
Gordon BA, Shelton JT, Bugg JM, McDaniel MA, Head D. Structural correlates of prospective memory. Neuropsychologia. 49: 3795-800. PMID 21982698 DOI: 10.1016/J.Neuropsychologia.2011.09.035 |
0.634 |
|
| 2010 |
Tse CY, Gordon BA, Fabiani M, Gratton G. Frequency analysis of the visual steady-state response measured with the fast optical signal in younger and older adults. Biological Psychology. 85: 79-89. PMID 20566389 DOI: 10.1016/J.Biopsycho.2010.05.007 |
0.707 |
|
| 2010 |
Schneider-Garces NJ, Gordon BA, Brumback-Peltz CR, Shin E, Lee Y, Sutton BP, Maclin EL, Gratton G, Fabiani M. Span, CRUNCH, and beyond: working memory capacity and the aging brain. Journal of Cognitive Neuroscience. 22: 655-69. PMID 19320550 DOI: 10.1162/Jocn.2009.21230 |
0.726 |
|
| 2008 |
Gordon BA, Rykhlevskaia EI, Brumback CR, Lee Y, Elavsky S, Konopack JF, McAuley E, Kramer AF, Colcombe S, Gratton G, Fabiani M. Neuroanatomical correlates of aging, cardiopulmonary fitness level, and education. Psychophysiology. 45: 825-38. PMID 18627534 DOI: 10.1111/J.1469-8986.2008.00676.X |
0.781 |
|
| 2006 |
Gratton G, Brumback CR, Gordon BA, Pearson MA, Low KA, Fabiani M. Effects of measurement method, wavelength, and source-detector distance on the fast optical signal. Neuroimage. 32: 1576-90. PMID 16872842 DOI: 10.1016/J.Neuroimage.2006.05.030 |
0.611 |
|
| 2006 |
Gratton G, Low KA, Maclin EL, Brumback CR, Gordon B, Fabiani M. Time course of activation of human occipital cortex measured with the event-related optical signal (EROS) Optics Infobase Conference Papers. DOI: 10.1364/Bio.2006.Md4 |
0.609 |
|
| 2006 |
Sutphen CL, Herries EM, Gordon BA, Benzinger TL, Xiong C, Cruchaga C, Ladenson JH, Fagan AM, Schindler SE. P4-275: THE EMERGING CEREBROSPINAL FLUID BIOMARKER SNAP-25 IS ELEVATED IN APOEε4 CARRIERS IN COGNITIVELY NORMAL INDIVIDUALS Alzheimer's & Dementia. 14: P1552-P1552. DOI: 10.1016/J.Jalz.2018.07.097 |
0.329 |
|
| 2006 |
Li Y, Wang G, Xiong C, McDade E, Fagan AM, Gordon BA, Benzinger TL, Aschenbrenner AJ, Hassenstab J, Bateman RJ. P2-072: A STATISTICAL METHOD FOR DETERMINING BIOMARKER THRESHOLD FOR ALZHEIMER'S DISEASE Alzheimer's & Dementia. 14: P694-P695. DOI: 10.1016/J.Jalz.2018.06.757 |
0.598 |
|
| 2006 |
Sato C, Barthélemy NR, Mawuenyega KG, Patterson BW, Gordon BA, Kanaan NM, Benzinger TL, Miller TM, Karch C, Bateman RJ. O3-01-03: TAU KINETICS IN NEURONS AND IN THE HUMAN CNS Alzheimer's & Dementia. 14: P1008-P1009. DOI: 10.1016/J.Jalz.2018.06.2772 |
0.468 |
|
| 2006 |
Roe CM, Babulal GM, Fagan AM, Benzinger TL, Stout SH, Hassenstab J, Gordon BA, Holtzman DM, Morris JC, Ances BM. O2-15-02: LONGITUDINAL COURSE OF PRECLINICAL AD USING THE A/T/N FRAMEWORK Alzheimer's & Dementia. 14: P660-P661. DOI: 10.1016/J.Jalz.2018.06.2725 |
0.427 |
|
| 2006 |
McCullough AA, Gordon BA, Christensen J, Dincer A, Keefe S, Flores S, Hornbeck RC, Bateman RJ, Morris JC, Ances BM, Benzinger TL. IC-P-207: EXAMINING THE ABILITY OF A TAU SPATIAL SPREAD METRIC TO INDICATE DISEASE PROGRESSION COMPARED TO AN INTENSITY-BASED APPROACH Alzheimer's & Dementia. 14: P170-P171. DOI: 10.1016/J.Jalz.2018.06.2274 |
0.586 |
|
| 2006 |
Dincer A, Gordon BA, LaMontagne PJ, Keefe S, Marcus DS, Morris JC, Benzinger TL. IC-P-162: REGIONAL CORTICAL THINNING PATTERNS IN COGNITIVELY IMPAIRED AND CONVERTER INDIVIDUALS USING OASIS-3 DATA Alzheimer's & Dementia. 14: P136-P137. DOI: 10.1016/J.Jalz.2018.06.2229 |
0.409 |
|
| 2006 |
Gordon BA, Su Y, McDade E, Cairns NJ, Morris JC, Bateman RJ, Benzinger TL. IC-02-01: THE RELATIONSHIP BETWEEN TAU PET AND AGE ACROSS THE LIFESPAN Alzheimer's & Dementia. 14: P1-P2. DOI: 10.1016/J.Jalz.2018.06.2044 |
0.567 |
|
| 2006 |
McCullough AA, Gordon BA, Christensen J, Dincer A, Keefe S, Flores S, Hornbeck RC, Bateman RJ, Morris JC, Ances BM, Benzinger TL. P3-401: EXAMINING THE ABILITY OF A TAU SPATIAL SPREAD METRIC TO INDICATE DISEASE PROGRESSION COMPARED TO AN INTENSITY-BASED APPROACH Alzheimer's & Dementia. 14: P1255-P1256. DOI: 10.1016/j.jalz.2018.06.1764 |
0.482 |
|
| 2006 |
Smith RX, Tanenbaum A, Strain JF, Gordon BA, Benzinger TL, Morris JC, Ances BM. IC-P-167: ALTERED RESTING-STATE FUNCTIONAL MRI SIGNAL ENTROPY IN TEMPORAL AND PARIETAL LOBES IN SPORADIC ALZHEIMER'S DISEASE Alzheimer's & Dementia. 14: P140-P140. DOI: 10.1016/J.Jalz.2018.06.1742 |
0.482 |
|
| 2006 |
Wang G, Xiong C, McDade E, Li Y, Aschenbrenner AJ, Hassenstab J, Fagan AM, Gordon BA, Benzinger TL, Morris JC, Bateman RJ. P1-119: CROSS-SECTIONAL AND LONGITUDINAL RELATIONSHIPS AMONG BIOMARKERS FOR DOMINANTLY INHERITED ALZHEIMER'S DISEASE AND ITS COMPARISON WITH SPORADIC AD Alzheimer's & Dementia. 14: P316-P316. DOI: 10.1016/J.Jalz.2018.06.122 |
0.67 |
|
| 2006 |
Gordon BA, Su Y, McDade E, Cairns NJ, Morris JC, Bateman RJ, Benzinger TL. P2-362: THE RELATIONSHIP BETWEEN TAU PET AND AGE ACROSS THE LIFESPAN Alzheimer's & Dementia. 14: P829-P830. DOI: 10.1016/J.Jalz.2018.06.1053 |
0.584 |
|
| 2004 |
Chang WP, Koelsch G, Wong S, Downs D, Da H, Weerasena V, Gordon B, Devasamudram T, Bilcer G, Ghosh AK, Tang J. In vivo inhibition of Abeta production by memapsin 2 (beta-secretase) inhibitors. Journal of Neurochemistry. 89: 1409-16. PMID 15189343 DOI: 10.1111/J.1471-4159.2004.02452.X |
0.303 |
|
| 2004 |
Chang W, Koelsch G, Wong S, Downs D, Da H, Weerasena V, Gordon B, Devasamudram T, Bilcer G, Ghosh AK, Tang J. P4-374 In vivo inhibition of brain Aβ level by memapsin 2 (β-secretase) inhibitors Neurobiology of Aging. 25. DOI: 10.1016/S0197-4580(04)81932-8 |
0.317 |
|
| Show low-probability matches. |
